Importance of DCD practices
John J. Fung (US)
Programme
Browse the programme by date and add sessions or individual talks to My Agenda.
Filter programme
Sunday, September 20, 2026
Satellite Program (Pre-congress activities)
Cockle Bay 1
Post-Graduate Course - Clinical Program
Post-Graduate Course - Clinical Program
Supported by
Cockle Bay 2
Post-Graduate Course - Fundamental and translational science
Post-Graduate Course - Fundamental and translational science
Supported by
Room C4.6
Global nursing and allied health leadership in organ donation and transplantation
Global nursing and allied health leadership in organ donation and transplantation
Organized by: TTS Allied Health Committee - In Collaboration with 
Supported by
Room C3.6
Pediatric Transplantation
Pediatric Transplantation
Room C4.4
Transplant Infectious Diseases (TID)
Transplant Infectious Diseases (TID)
|
Organized by
|
In collaboration with
|
Room C4.5
Women in Transplantation
Women in Transplantation
Organized by: 
Room C3.4-C3.5
TSANZ Research Accelerator Showcase
TSANZ Research Accelerator Showcase
Organized by: 
Room C4.9
How to do controlled and uncontrolled DCD in the world
How to do controlled and uncontrolled DCD in the world
Presentations
Introduction DCD future development in pediatrics
Gabriel E. Gondolesi (US)
Introduction of DCD international practices
Marti Manyalich Vidal (ES)
Detection and evaluation of DCD donors
Mauricio Pereira (ES)
Family communication in the context of DCD donation
Chloë Ballesté Delpierre (ES)
Adequation of life sustaining therapy and death declaration
Sara Alcantara Carmona (ES)
Normothermic Regional Perfusion (A-NRP / TA-NRP)
Lilia Martinez de la Maza (SE)
Ex-Situ machine perfusion
Joaquim Albiol (ES)
Ethic & Legal Barriers for NRP and TANRP in DCD worlwide
Beatriz Domínguez-Gil (ES)
Conclusion
Marti Manyalich Vidal (ES)
Parkside 1&2
Transplant Recipients & Carers Forum and Lunch
Transplant Recipients & Carers Forum and Lunch
Registration: https://thegreatestgift.transplant.org.au
Hear from Australian and international leaders in transplantation alongside transplant recipients who will share their personal experiences and insights.
Topics Include:
Advances in transplantation
The emotional journey of transplantation
Living well after transplantation
Participants will also have the opportunity to engage in small-group discussions, ask questions and connect with others who understand the transplant journey.
Following the forum, enjoy a casual lunch and connect with members of the transplant community from across Australia.
Further details and registration: https://thegreatestgift.transplant.org.au
No lectures assigned yet.
Offsite
The Transplant Thank You Walk - ICC Convention Forecourt
The Transplant Thank You Walk - ICC Convention Forecourt
Location: ICC Convention Forecourt
Registration: https://thegreatestgift.transplant.org.au
Join a gentle 1.5km community walk around Darling Harbour and across the iconic Pyrmont Bridge.
Together we will:
Honour organ and tissue donors and their families
Recognise living donors
Celebrate transplant recipients
Thank the healthcare professionals, researchers and advocates whose work continues to transform lives
This special walk provides an opportunity for the transplant and donor community to come together in gratitude, remembrance and hope.
Further details and registration: https://thegreatestgift.transplant.org.au
No lectures assigned yet.
Room C3.4-C3.5
SOBI Symposium - Beyond the transplant: Advances in our understanding of C3G & primary IC-MPGN
SOBI Symposium - Beyond the transplant: Advances in our understanding of C3G & primary IC-MPGN
Room C4.5
CBS-TTS DEI Symposium - From principles to practice: Advancing diversity, equity, and inclusion in transplantation
CBS-TTS DEI Symposium - From principles to practice: Advancing diversity, equity, and inclusion in transplantation
Chairs
Nazia Selzner (CA) · Cynthia Tsien (CA)
Supported by: 
in partnership with: 
Presentations
13:30
Welcome and session introduction
Nazia Selzner (CA)
13:35
2SLGBTQI-Inclusive care in organ donation and transplantation
Carmen Hrymak (CA)
13:50
Innovations to improve equity and access in pediatric kidney transplantation
Aviva Goldberg (CA)
14:05
Mindfulness and meaning in transplant medicine: Supporting the workforce
Marina Berenguer (ES)
14:20
Q&A and closing remarks
Cynthia Tsien (CA)
Opening Ceremony & Plenary Session
Darling Harbour
Opening Ceremonies “Innovation through Collaboration”
Opening Ceremonies “Innovation through Collaboration”
Chairs
John J. Fung (US) · Steve Chadban (AU)
Presentations
Welcome to Australia
Welcome address from TTS President
John J. Fung (US)
Welcome address from TSANZ President
Nicole Isbel (AU)
TTS 60th Anniversary
Jeremy Chapman (AU)
Welcome address from the Parliamentary Secretary for Health and Parliamentary Secretary for Regional Health
Michael J. Holland (AU)
Haka and other performances by Te Aranganui
Te Aranganui (AU)
Transplantation: Walking both sides of the journey
Steve Chadban (AU)
Panelist
Nicole Jane Scholes-Robertson (AU)
Panelist
Melanie Wyld (AU)
Panelist
Robert A. Montgomery (US)
TTS Thomas Starzl Innovation Award Introduction
John J. Fung (US)
🎗2026 Starzl Award recipient
Anthony Jake Demetris (US)
Introduction to the TTS - Dr. Sanjeev Kanoria Liver Transplant Award
Sanjeev Kanoria (GB)
Introduction to the recipients of the TTS - Dr. Sanjeev Kanoria Liver Transplant Award
Nadey Hakim (GB)
🎗Recipient of the 2026 TTS - Dr. Sanjeev Kanoria Liver Transplant Award
Peter J. Friend (GB)
🎗Recipient of the 2026 TTS - Dr. Sanjeev Kanoria Liver Transplant Award
Maria Amalia Matamoros (CR)
Distribution of Congress Scientific Awards
John J. Fung (US)
Distribution of the Leslie B. Brent and Anthony P. Monaco Awards
John J. Fung (US)
Darling Harbour
Plenary Session 1
Plenary Session 1
Chair
Medhat Askar (US)
Presentations
17:15
Early clinical experience with gene-edited porcine kidney xenotransplantation in four living human recipients
Leonardo Riella (US)
17:25
Validating RenalAgent: An Artificially Intelligent Autonomous Agent for Renal Pathology
Harry Robertson (AU)
17:35
Artificial intelligence in medicine
Karin Verspoor (AU)
18:00
Closing remarks
John J. Fung (US)
Hall 1-2
Welcome Reception
Welcome Reception
No lectures assigned yet.
TTS Connect & Converse Theatre
Interview, Q&A discussions and Jeopardy
Interview, Q&A discussions and Jeopardy
Chair
Macey L. Levan (US)
Presentations
18:45
Q&A discussion with plenary speaker
Karin Verspoor (AU)
18:45
Q&A discussion with 2026 Starzl Award recipient
Anthony Jake Demetris (US)
19:00
Jeopardy Quizz
Rebekah Lane (NZ)
Jeopardy Quizz
Bradley Gardiner (AU)
Monday, September 21, 2026
Morning Abstract and Concurrent Sessions
Parkside 1&2
Takeda Corporate Breakfast Symposium on Illuminated constellations: How diverse institutional experiences guide practical CMV management
Takeda Corporate Breakfast Symposium on Illuminated constellations: How diverse institutional experiences guide practical CMV management
Chair
Camille N. Kotton (US)
Supported by
Presentations
08:00
Welcome and Introductions
Camille N. Kotton (US)
08:03
Evidence informing earlier action in CMV management
Camille N. Kotton (US)
08:09
Recognizing refractory CMV signals early after transplant
Gang Huang (CN)
08:24
Managing patients when conventional therapy isn’t tolerated
Glen P. Westall (AU)
08:39
How evolving guidelines illuminate day-to-day clinical practice
Camille N. Kotton (US)
08:49
Panel discussion and Conclusion remaks
Camille N. Kotton (US)
Cockle Bay 1
Advancing living donor kidney transplantation - 1
Advancing living donor kidney transplantation - 1
Presentations
Oral Presentation
08:00
Socioeconomic, demographic, and lifestyle factors associated with living kidney donation among individuals exploring the possibility of donating
Allan Massie (US)
08:10
Establishing an Operational Framework for a Pan-European Kidney Exchange Programme (EURO-KEP)
Per Lindner (SE)
Mini-Oral Presentation
08:20
The impact of continuous matching on compatible pairs in the Australian and New Zealand Kidney Exchange Program (ANZKX)
Stella McGinn (AU)
08:27
Sex and gender as prognostic factors for health outcomes among living kidney donors: A systematic review
Eswari Vilayur (AU)
08:34
Comparison of erector spinae plane block vs quadratus lumborum type ii block for post-operative analgesia in renal transplant donors
Sameer Sethi (IN)
Rapid-Fire Presentation
08:41
Use of transit-time flow measurement (TTFM) for quantitative assessment of macroperfusion in living-donor kidney transplantation
Mikhail Petryaev (RU)
08:47
Short-term Renal and Metabolic Outcomes in Obese vs Non-Obese Living Kidney Donors
Ignatius Tang (US)
Cockle Bay 2
Immunoregulation - T and B cells
Immunoregulation - T and B cells
Chairs
Shane Grey (AU) · Michaela Lucas (AU)
Presentations
Oral Presentation
Characterisation of organ donor tissue immunopeptidomes reveals targets of alloreactive CD8+ T cells
Nicole Mifsud (AU)
Immunogenomic landscape of T cell repertoires after human lung transplantation and its clinical significance
Jianing Fu (US)
Achievement of donor-specific hypo-responsiveness after kidney transplantation under conventional immunosuppression is associated with impaired IL-2 production and reduction of T cells recognizing donor HLA
Keisuke Maeda (JP)
Aberrant autoantibody IgG glycosylation seen in Primary Graft Dysfuntion patients modifies complement activation and macrophage activation in-vitro
Hassan Moussa (US)
Aging Attenuates Humoral Allosensitization Through B Cell-Intrinsic Alterations
Friederike Martin (DE)
Room C3.3
Metabolic health and kidney transplant outcomes
Metabolic health and kidney transplant outcomes
Chairs
Mads Hornum (DK) · Katharine Hegerty (AU)
Presentations
Mini-Oral Presentation
08:00
Predictive value of early continuous glucose monitoring–detected hyperglycaemia for post-transplant diabetes mellitus among non-diabetic kidney transplant recipients
Abhilash Tirkey (IN)
08:07
SGLT-2i use and risk of mortality and heart failure in kidney transplant recipients with type 2 diabetes.
Babak Orandi (US)
08:14
Preoperative Assessment of Muscle Mass in Kidney Transplant Recipients: Comparison of DXA, CT, and InBody, and Their Predictive Value for Functional Impairment
Dahyun Jung (KR)
08:21
Temporal changes in gut microbiota across different phases after kidney transplantation
Yunchao Wang (CN)
08:28
Impact of Changes in Smoking Behavior Before and After Kidney Transplantation on Graft and Cardiovascular Outcomes: A Nationwide Cohort Study
Sangwan Kim (KR)
08:35
Metabolic bariatric surgery vs GLP-1 receptor agonists in dialysis patients with diabetes and obesity: a target trial emulation study
Babak Orandi (US)
08:42
Perspectives and experiences of clinicians on substance use in patients with chronic kidney disease and kidney transplants
Anastasia Hughes (AU)
Room C3.4-C3.5
Organ preservation 1
Organ preservation 1
Chairs
Gavin Pettigrew (GB) · Natasha Rogers (AU)
Presentations
Oral Presentation
08:00
🎗Efficacy of 10 degrees Celsius static cold storage for warm ischemic kidneys in MHC inbred CLAWN miniature swine
Akiyuki Iwamoto (JP)
08:10
Extended Normothermic Machine Perfusion Supports Functional Preservation and Induces Regeneration in Ex Vivo Porcine Livers
Zhen Sun (CN)
Mini-Oral Presentation
08:20
Ischemia-Free Procedure Protects Extended Criteria Donor Livers by Avoiding Double Hits of Ischemia-reperfusion Injury
Yu Jia (CN)
08:27
A multifunctional polymer for organ preservation and graft survival after transplantation
Lei Fang (CN)
08:34
Advanced perfusion techniques eliminate outcome gaps between DCD and DBD liver transplantation
Tiffany Lim (US)
08:41
MDSC-Derived Extracellular Vehicles Attenuate Renal Ischemia-Reperfusion Injury by Delivering miR-106b-5p to Target PDK4-Mediated Metabolic Reprogramming and Ferroptosis
Puxun Tian (CN)
08:48
Ex Vivo Whole Eye Perfusion System
Varun Kopparthy (US)
Room C3.6
Advancing kidney transplant equity and access: Global, national, and systems-level perspectives in transplantation
Advancing kidney transplant equity and access: Global, national, and systems-level perspectives in transplantation
Chairs
Dorry Segev (US) · Tracey Ying (AU)
Presentations
Mini-Oral Presentation
08:00
Sex and intersectional disparities in cardiovascular mortality for kidney transplant patients: A binational population-based data-linkage study 1988-2022 in Australia and New Zealand
Samantha Giang (AU)
08:07
A Decade of Progress in Organ Transplantation in India: National Trends and Growth Patterns (2015–2024)
Anil Kumar (IN)
08:14
Individual and center level determinants of progression from kidney transplant referral to kidney transplantation in the United States: A national EHR study
Michal Mankowski (US)
08:21
Predictors of brain death in computed tomography reports in a Portuguese cohort from 2011 to 2024
António Gonçalves (PT)
08:28
Successful adoption of an electronic donor record management platform for organ and tissue donors across Australia
Christian Rivas (US)
Rapid-Fire Presentation
08:35
Demographic and Clinical Profile of Active Patients on the Kidney Transplant Waiting List in Saudi Arabia: A 2025 National Analysis
Jamail Ghafwari (SA)
08:40
Thailand’s first national program for deceased organ donor detection: Closing the gap through early identification
Korntip Phonphok (TH)
08:45
Prediction of the potential impact of heart after liver transplant (HALT) on the liver transplant waitlist in the United States
Catherine Kling (US)
08:50
Organ Donation After Medical Assistance in Dying (MAiD): A Global Overview of Short- and Long-Term Clinical Outcomes
Angel Ngo (CA)
Room C4.1
Personalizing immunosuppression in liver transplantation: From microbiome to malignancy
Personalizing immunosuppression in liver transplantation: From microbiome to malignancy
Chairs
Jennifer Garcia (US) · Ashwin Rammohan (IN)
Presentations
08:00
Personalizing immunosuppression in liver transplant recipients: Balancing rejection, infection and malignancy
Simone I. Strasser (AU)
08:20
Personalizing IS in complex liver transplant cases: Autoimmune disease, NASH, elderly recipients
Marina Berenguer (ES)
08:40
Tacrolimus intrapatient variability in solid organ transplantation
Juhan Lee (KR)
Room C4.5
Acute-on-chronic liver failure and liver transplantation: From mechanisms to clinical futility
Acute-on-chronic liver failure and liver transplantation: From mechanisms to clinical futility
Chairs
Dinesh Jothimani (IN) · Jongman Kim (KR)
Presentations
Oral Presentation
08:00
Persistent dysregulation of bile acid metabolism after liver transplantation: a longitudinal metabolomic analysis
Anna Posthumus (NL)
08:10
🎗Identification and analysis of factors influencing the futility of liver transplantation in patients with acute-on-chronic liver failure: A nationwide multicenter cohort study
Qinfen Xie (CN)
Mini-Oral Presentation
08:20
Pre-Transplant Kidney Vulnerability: An Independent Predictor of Major Adverse Kidney Events Following Liver Transplantation
Saurabh Puri (IN)
08:27
Targeting the ELF1-HGFAC axis via Normothermic Machine Perfusion (NMP) rescues regenerative capacity in human Acute-on-Chronic Liver Failure
Meiting Qin (CN)
08:34
Analysis of the Impact of Graft Quality and Volume on Early Allograft Dysfunction After Ex-vivo Liver Resection and Autotransplantation and Construction of a Predictive Model
Abuduhaiwaier Abuduhelili (CN)
08:42
Paediatric acute liver failure and pancytopenia: A single centre retrospective case series
Natasha Hardikar (AU)
Room C4.6
Vasculopathy: A tale of three organs
Vasculopathy: A tale of three organs
Chairs
Hatem Amer (US) · Linda C. Cendales (US)
Presentations
08:00
Graft-localized programmable immunosuppression enables durable survival in vascularized composite allotransplantation
Vijay Gorantla (US)
08:15
What we know and don't but should about cardiac allograft vasculopathy
Kavitha Muthiah (AU)
08:36
What should we continue to learn from renal allograft pathology
Mariam Alexander (US)
Room C4.7
Advancing heart transplantation: Preservation strategies, immune monitoring, and rejection mechanisms
Advancing heart transplantation: Preservation strategies, immune monitoring, and rejection mechanisms
Chairs
Peter MacDonald (AU) · Anne Dipchand (CA)
Presentations
Oral Presentation
08:00
Australian outcomes for hypothermic machine perfusion in heart transplant recipients since 2021: A retrospective, single centre study
Natasha Dehghani (AU)
08:10
Validation of a two-threshold algorithm (2TA) combining donor-derived cell-free DNA (dd-cfDNA) fraction and quantity to detect Heart transplant rejection defined by gene expression changes
Cesar Escrig (CH)
Mini-Oral Presentation
08:20
Sustained Myocardial Viability Following a 32-Hour Ex Vivo Preservation: The Impact of Intermittent Cold Storage and 24-Hour Normothermic Perfusion
Syed Raza (US)
08:27
Does significant tricuspid regurgitation early after heart transplantation resolve?
Sakae Takenaka (US)
08:34
Long term rejection outcomes in donation after circulatory death heart transplantation
Katherine Wang (AU)
Rapid-Fire Presentation
08:41
Investigation of the relationship between antibody-mediated rejection and serum interleukin-40 level in heart transplant patients
Bilkay Basturk (TR)
08:46
Antibody mediated rejection is equivalent in donation after circulatory death and brain death donor cohorts: a ten-year Australian analysis
Campbell MacLean (AU)
Room C4.8
Surgical innovation and technical advances in transplantation
Surgical innovation and technical advances in transplantation
Chairs
Peter G. Stock (US) · Dieter Broering (SA)
Presentations
Oral Presentation
08:00
Overcoming ischemic barriers: the first clinical experience of NRP-assisted in situ split liver transplantation with DCD grafts
Jian He (CN)
08:10
🎗From niche to multidisciplinary application: advancing non‑vascularized rectus fascia as an innovative allograft in a single-center prospective cohort
Ewout Muylle (BE)
Mini-Oral Presentation
08:20
Safety and Outcomes of External Biliary Drainage in Living-Donor Liver Transplantation: Report of a Prematurely Terminated Randomized Controlled Trial
Su Young Hong (KR)
08:27
Largest Single-Center Experience of Robot-Assisted Kidney Transplantation: Outcome Analysis
Anant Kumar (IN)
08:34
Impact of Large-for-Size Grafts on Outcomes After Side-to-Side Cavocaval Anastomosis in Adult Deceased-Donor Liver Transplantation
Eui Soo Han (KR)
Room C4.9
Local/Regional insights for global organ donation advancement
Local/Regional insights for global organ donation advancement
Presentations
08:00
Latin America
Gustavo Fernandes Ferreira (BR)
08:10
Europe
Marti Manyalich Vidal (ES)
08:20
Middle-East - North Africa
Refaat Kamel (EG)
08:30
Asia
Susumu Eguchi (JP)
08:40
Oceania
Helen Opdam (AU)
08:50
North America
Atul Humar (CA)
Room C4.10
Cell-based immunomodulation and transplant tolerance: From mechanisms to long-term outcomes
Cell-based immunomodulation and transplant tolerance: From mechanisms to long-term outcomes
Presentations
Oral Presentation
08:00
HLA-Silenced Cell Therapy Enhances Donor Lung Recovery and Mitigates Primary Graft Dysfunction in a Porcine Transplant Model
Franziska Olm (SE)
Mini-Oral Presentation
08:10
Gene Editing with a Novel Binary Retroviral Vector System to Reduce HLA Class I Allogenicity
Katrin Hacke (US)
08:17
Pramlintide‑expressing stem cell‑derived beta cells limit islet amyloid in a transplantation model of type 1 diabetes
Saumadritaa Kar (CA)
08:24
10-year malignancy outcomes following autologous polyclonal ex-vivo-expanded Treg therapy in renal transplantation
Audrey Au Yong (GB)
08:31
Driving naïve Tregs toward alloantigen memory-like Tregs using a novel expansion protocol
Xuan Han (AU)
08:38
Attenuation of Chronic Renal Allograft Rejection in Rats by Exosomes from Human induced Pluripotent Stem Cell derived Nephron Progenitor Cells
Haiwei Chen (CN)
Room C4.11
Pediatric kidney
Pediatric kidney
Chairs
Tom Blydt-Hansen (CA) · Matthew Sypek (AU)
Presentations
Oral Presentation
08:00
A novel image-guided size-matching strategy enables living-donor kidney transplantation in very small pediatric recipients
Johan Nordström (SE)
08:10
Potential neonatal deceased donors after neurological and circulatory determination of death: a National Registry-Based Cohort Study
Rebecca Barzegar (AU)
08:20
Understanding why parents say yes or no to organ donation when their child dies: a mixed method study
Leah McLaughlin (GB)
Mini-Oral Presentation
08:30
Lower cumulative blood pressure after pediatric kidney transplantation is associated with better graft function and survival: A longitudinal analysis of the CERTAIN registry
Carl Grabitz (DE)
08:37
Sex-specific associations of HDL cholesterol with atherosclerosis in pediatric chronic kidney disease
Arshi Choudhary (DE)
08:44
Excellent clinical long-tong outcomes of en-bloc kidney transplantation from small donors (age≤6 months) despite the higher risk of thrombosis
Lan Zhu (CN)
08:51
Outcomes and challenges of paediatric kidney transplantation in small recipients: A 20-year retrospective study
Thozama Siyotula (ZA)
Plenary and Concurrent Sessions
Darling Harbour
Plenary Session 2
Plenary Session 2
Room C4.9
Beyond survival: Addressing mental health in transplantation
Beyond survival: Addressing mental health in transplantation
Presentations
09:15
Why survival alone is not sufficient for transplant successs
Mariel Nöhre (DE)
09:30
Psychological distress across the transplant journey
Iris Fontanilla (NZ)
09:45
Practical strategies for integrating mental health in transplant care
Ming Hwei Yek (US)
10:00
Panel Discussion
Discussion Period (AU)
Room C4.10
Dedicated donor care units: Centralized donor transfer and outcome optimization
Dedicated donor care units: Centralized donor transfer and outcome optimization
Chairs
David Thomson (ZA) · Dale Gardiner (GB)
Presentations
09:15
25 years of innovation: The St. Louis donor care unit
Gary F. Marklin (US)
09:35
The US donor care unit landscape
Jennifer Prinz (US)
09:55
The first comprehensive-DCU developed in China leading the change of the procurement model
Hui Li (CN)
10:10
Panel Discussion
Discussion Period (AU)
Coffee Break / Exhibits and Poster Viewing
Hall 1-2
Coffee Break
Coffee Break
No lectures assigned yet.
TTS Connect & Converse Theatre
Interview and Q&A discussions with plenary speakers
Interview and Q&A discussions with plenary speakers
Chair
Jay Fishman (US)
Presentations
10:40
Q&A discussions
Tatsuo Kawai (US)
Q&A discussions
Anoma Nellore (US)
Q&A discussions
Richard N. Pierson (US)
Q&A discussions
Wayne J. Hawthorne (AU)
Q&A discussions
Luz Padilla (US)
Abstract and Concurrent Sessions
Cockle Bay 1
Advancing living donor kidney transplantation - 2
Advancing living donor kidney transplantation - 2
Chairs
Elias David-Neto (BR) · Craig Coorey (AU)
Presentations
Oral Presentation
Kidney failure after living kidney donation in Australia: A national registry linkage study 2004-2023
Melanie Wyld (AU)
Mapping the Landscape of European Kidney Exchange Programmes: A Comparative Analysis of Operational and Immunological Frameworks
Per Lindner (SE)
Mini-Oral Presentation
🎗Health-related quality of life and psychosocial outcomes after living kidney donation in Rwanda
Emmanuel Muhawenimana (RW)
Survival Benefit of ABO- or HLA-incompatible living donor kidney transplantation in the elderly.
Sangwan Kim (KR)
“Self” reactive antibodies in paediatric living donor pairs: ANZKX perspective
Megan Kummrow (AU)
Assessing the impact of the living kidney donor transplant process on living donors’ relational closeness with family, friends, and acquaintances
Carrie Thiessen (US)
Cockle Bay 2
Infection and biomarkers
Infection and biomarkers
Chairs
Megan Levings (CA) · James Lan (CA)
Presentations
Oral Presentation
11:00
Peripheral immune profiles and renal impairment parameters synergistically predict fatal SARS-CoV-2 infection in a kidney transplant cohort
Yu Cui (CN)
Rapid-Fire Presentation
11:10
Standard-of-Care-Informed Unsupervised Learning and Multi-Biomarker Modeling for Diagnosis of Kidney Transplant Rejection
John Friedewald (US)
11:15
Spatial and Temporal Dynamics of REG3A as a Biomarker of Intestinal Allograft Health and Rejection
Douglas Farmer (US)
11:20
Comparative Perioperative Kinetics of NGAL and Cystatin C in Predicting Acute Kidney Injury After Liver Transplantation
Saurabh Puri (IN)
11:25
Torque teno virus viral load as a biomarker of rejection, opportunistic infection, and infection recovery during the first six months post kidney transplantation
Ramyangshu Chakraborty (GB)
11:30
CMV-DNA Level in zero-hour kidney tissue is associated with Risk of post-transplant CMV Infection in D+/R− Living Donor Kidney Transplantation
Takehiro Ohyama (JP)
11:35
Multidimensional donor–recipient HLA genetic features in relation to post-liver transplant infection risk
Mingyue Li (CN)
11:40
Tackling infectious threats post transplantation dash a retrospective cohort study of opportunistic infections in the first year post renal transplant semicolon determinants of infectious risk and impact of pharmacist-led intervention
Justin Beardsley (AU)
11:45
Circ-MAPK4 promotes pyroptosis-associated liver fibrosis by regulating the miR-125a-3p–NLRP3 inflammasome axis
Chao Wang (CN)
11:50
Host and pathogen pharmacogenetics in Pneumocystis jirovecii pneumonia after kidney transplantation: a retrospective cohort and case–control study
Dirk Kuypers (BE)
11:55
Impact of Cytomegalovirus Infection on IgG Glycosylation in Kidney Transplant Recipients
Marta Crespo Barrio (ES)
Room C3.3
Risk determinants for kidney transplant outcomes
Risk determinants for kidney transplant outcomes
Presentations
Mini-Oral Presentation
11:00
Patient and graft survival in kidney transplant recipients with lupus nephritis: an ANZDATA registry analysis
Jacqueline Evans (AU)
11:07
Donor-Derived Cell-Free DNA at Biopsy Predicts Long-Term Renal Allograft Functional Decline Beyond Histologic Diagnosis: A Prospective Single-Center Study
Eunjeong Kwon (KR)
11:14
Age-interactions and death-censored graft survival - A collaborative study (CTS) report
Christian Unterrainer (DE)
11:21
Association of early post-transplant tacrolimus time in therapeutic range (TTR) with clinical outcomes after kidney transplantation: A multicenter cohort study using clinical data warehouse (CDW)
Eunju Jang (KR)
11:28
Treatment outcomes and allograft survival in kidney transplant recipient with tertiary hyperparathyroidism
Anant Pilawan (IN)
11:35
Acute Rejection in Older Kidney Transplant Recipients: Temporal trends and long-term outcomes
Tracey Ying (AU)
11:42
Correlation of Tacrolimus trough levels with Graft events in Renal Transplant Recepients – An Ambispective Study
Swarnalatha Guditi (IN)
11:49
Cause of Death Among Kidney Transplant Waitlisted Candidates: A Population-Based Study Using Data Linkage in Australia and New Zealand, 2006-2018
Yao Wu (AU)
Rapid-Fire Presentation
11:56
Integrating Serological CREG and Molecular Eplet Analysis Enhances Characterization of Alloreactivity in Sensitized Renal Transplant Recipients: A Single-Centre Study
Chippy C S (IN)
Room C3.4-C3.5
Immunoregulation 1
Immunoregulation 1
Chairs
Anita Chong (US) · Maria-Luisa Alegre (US)
Presentations
Oral Presentation
11:00
🎗Selective loss of donor specific IFNγ regulation and B cell subset remodeling precede de novo donor specific antibody formation in kidney transplantation
Sumoyee Basu (GB)
11:10
🎗CAR-Tregs synergize with anti-thymocyte globulin and rapamycin to delay skin allograft rejection
Manjurul Haque (CA)
Mini-Oral Presentation
11:20
Investigating the role of kidney-resident natural killer cells in the control of human cytomegalovirus within the renal allograft
Harry Persaud (GB)
Rapid-Fire Presentation
11:27
Highly Reactive Paternal Alloreactive Memory B Cells Defined by HLA Antibody Profiling of Polyclonal Culture Supernatants in female kidney transplant recipients
Marta Crespo Barrio (ES)
11:32
Beyond the Crossmatch: Eplet-Based Risk Stratification of FCXM-SAB Discordance Identifies Novel Rejection-Associated Eplets in Renal Transplant Candidates — A South Asian Perspective
Lekha Rani (IN)
11:37
Multi-Omic Mendelian Randomization and Experimental Validation Identify NDUFA13 as a Mitochondrial Regulator in Renal Allograft Fibrosis
Qinghuan Shen (CN)
11:42
Loss of NLRP3 Function Triggers a Hyper-Accelerated Islet Allograft Rejection
Paulomi Mehta (AU)
11:47
🎗Immunogenic eplet mapping to histologically distinct alloimmune phenotypes in live donor renal transplantation characterisation of class I and class II immunogenic eplets in human transplant pairs with biopsy confirmed tissue phenotyping
Kapil Vijaykumar Gothwal (IN)
11:52
FGIN-1-27 selectively suppresses human T helper 1 and T helper 17 cell proliferation while sparing regulatory T cells
Chloe Sligar (AU)
Room C3.6
Artificial intelligence and machine learning in transplantation: From pathology to predictive clinical decision support
Artificial intelligence and machine learning in transplantation: From pathology to predictive clinical decision support
Chairs
Matthew Sypek (AU) · Harry Robertson (AU)
Presentations
Oral Presentation
🎗Development and validation of an interpretable machine learning model for the prediction of early allograft failure following liver transplantation
Jiang Liu (HK)
DeepSeek in kidney transplantation: Benchmarking and multi-center evaluation for patient education and clinical decision support
Runmin Ding (CN)
Leveraging large languagemodels for systematic thematic analysis in transplant research: Comparative findings across two qualitative studies
Carolyn Sidoti (US)
Development and validation of machine learning models using inflammatory indices to predict de novo malignancies after kidney transplantation: A multicenter retrospective study
Yunchao Wang (CN)
Mini-Oral Presentation
Artificial intelligence–enhanced prediction of delayed graft function after kidney transplantation: A national registry study
Madhab Ray (US)
Comparison of accuarcy of AI-powerwed anatomical landmark based volumetry and cetroidal voronoi tessellation-based Volumetry in Living Donor Liver Transplantation
Jinsoo Rhu (KR)
Room C4.1
Intestinal transplantation
Intestinal transplantation
Chairs
Tomoaki Kato (US) · Yaron Avitzur (CA)
Presentations
Oral Presentation
Machine perfusion strategies in intestinal transplantation: HOPE outperforms normothermic, subnormothermic and static preservation in an experimental model
Javier Serradilla (ES)
Comparison of Hypothermic Oxygenated and Normothermic Machine Perfusion of Human Small Intestine for Transplantation
Koki Takase (US)
Intestinal Transplantation for Pseudomyxoma Peritonei: Outcomes from a Collaborative Peritoneal Malignancy and Transplant Programme
Helen Stark (GB)
Can Pre-operative Factors Predict Outcomes in Intestinal Transplantation for Pseudomyxoma Peritonei?
Charlotte Yates (GB)
Donor outcome in living-donor intestinal transplantation
Fang Kuan Chiou (SG)
Room C4.4
DCD: Controlled and uncontrolled—Where are we going?
DCD: Controlled and uncontrolled—Where are we going?
Presentations
11:00
Potential donors: Controlled and un-Controlled
Marti Manyalich Vidal (ES)
11:10
Role of ICU physicians
Sara Alcantara Carmona (ES)
11:20
Ethics for DCD: How to advance?
David Thomson (ZA)
11:30
Who should Canulate?
Lilia Martinez de la Maza (SE)
11:40
Which organs to implant, which ones to pump after NRP
Joaquim Albiol (ES)
11:50
Question Period
Discussion Period (AU)
Room C4.5
Transplant oncology in HCC and cholangiocarcinoma
Transplant oncology in HCC and cholangiocarcinoma
Chairs
Julie K. Heimbach (US) · Sudha Kodali (US)
Presentations
Oral Presentation
Immune Checkpoint Inhibitor-Based Downstaging Therapy for HCC Beyond the Milan Criteria: A Multicentre, Retrospective, Matched Cohort Study on Post-Liver Transplant Outcomes
Meiching Ong (CN)
A Retinoid Metabolism–MIF Axis Drives Immune Evasion of Circulating Tumor Cells in Hepatocellular Carcinoma
Ruilin Cai (CN)
The impact of the gut-liver axis on intrahepatic NK cell activity: Identifying modulators of efficacy in donor-derived NK cell therapy for HCC recurrence after liver transplantation
Masahiro Ohira (JP)
A Donor Risk Factor Inclusive Advanced Machine Learning Equation For Predicting Cholangiocarcinoma Recurrence After Liver Transplantation
Andrea Schlegel (US)
Temporal trends in the etiologies of hepatocellular carcinoma and non-hepatocellular carcinoma associated liver transplants in the US in the last decade
Behnam Saberi (US)
Mini-Oral Presentation
Stereotactic body radiotherapy as neoadjuvant treatment in liver transplantation for klatskin tumor
Aliaksei Shcherba (BY)
Room C4.6
Patient-centered outcomes and psychosocial determinants in kidney transplantation: From digital health to life course impacts
Patient-centered outcomes and psychosocial determinants in kidney transplantation: From digital health to life course impacts
Chairs
Audrey Au Yong (GB) · Adem Safak (TR)
Presentations
Mini-Oral Presentation
Pilot randomised controlled trial of Advanced Recovery Room care post living donor kidney transplantation
Karthik Venkataraman (AU)
Graft outcomes following pregnancy with a functioning kidney transplant in Australia and New Zealand
Su Jen Chua (AU)
Identifying research priorities in kidney transplantation: a priority setting partnership with patients, caregivers and healthcare professionals.
Nicole Jane Scholes-Robertson (AU)
Mental illness and access to kidney transplantation in universal healthcare systems: a multi-national population-based cohort study
James Hedley (AU)
A national cross-sectional study exploring acceptability and attitudinal domains towards patient-led acute rejection surveillance in liver transplantation
Omar Quidwai (IE)
The implementation of the Stanford integrated psychosocial assessment for transplantation and association with clinical outcomes in a tertiary care hospital in the United Arab Emirates
Fatima Alzaabi (AE)
Burnout in transplant professionals: State of the art and call to action
Vanessa Silva e Silva (CA)
Room C4.7
Organ donation pathways and practices
Organ donation pathways and practices
Chairs
Maria Gomez (AE) · Tina Coco (AU)
Presentations
Oral Presentation
11:00
Trusted faces, stronger voices: community-driven engagement can drive organ donation
Gail Moloney (AU)
11:10
The Development of Nursing Service System for Organ and Eye Donation Patients at Udon Thani Hospital
Sasipin Mongkolchai (TH)
11:20
Towards a Simpler Consent Conversation, Is it Achievable?
Olive McGowan (GB)
Mini-Oral Presentation
11:30
The Resuscitation Paradox: Why Potential Donors do not translate into Organ Donors in India
Sunil Shroff (IN)
11:37
Impact of structured national quality audits on deceased donor hospital performance: A three‑year comparison across 2023–2025
Tanvi Agarwal (AE)
Rapid-Fire Presentation
11:44
From Volume Growth to Quality Governance: A Five-Year Longitudinal Analysis of Organ Donation and Transplantation Development in China, 2020–2024
Jie Zhao (CN)
11:49
A Demographic and Structural Profile of Potential Donor Families in the United Arab Emirates: A Three-Year Multi-Center Analysis (2023–2025)
Lijamol Joseph (AE)
11:54
Disclosure of identifying information in transplantation: a diversity of views.
Anthony Cignarella (AU)
Room C4.8
The -omic era in allograft pathology
The -omic era in allograft pathology
Presentations
11:00
Does metabolic phenotype in the kidney affect transplant outcome?
Ana Konvalinka (CA)
11:20
Endogenous peptides in T cell allorecognition and beyond – Lessons from preclinical models
Alexandra Sharland (AU)
11:40
What metabolic interactions drives fibrosis and repair in organ transplantation?
Ton J. Rabelink (NL)
Room C4.9
Transplantation journals: Updates and opportunities
Transplantation journals: Updates and opportunities
Chairs
Stefan Tullius (US) · Fadi Issa (GB)
Presentations
11:00
Structure, achievements, goals – Getting your work published, recognized and highlighted
Stefan Tullius (US)
11:20
Transplant-Direct: The online campaign journal with an own agenda
Edward Geissler (DE)
11:40
AI and publishing: When, how and what is legit?
Germaine Wong (AU)
Room C4.10
Complex multi-organ transplantation: Outcomes, innovation, and allocation challenges
Complex multi-organ transplantation: Outcomes, innovation, and allocation challenges
Presentations
Oral Presentation
11:00
Delayed bleeding after simultaneous pancreas and kidney transplantation – A systematic review and single-centre experience
Zekun Chen (AU)
11:10
Eplet Mismatching as a Predictor of Acute Rejection in Simultaneous Pancreas Kidney Transplantation
Xiangyu Lan (CN)
11:20
Pregnancy outcomes after simultaneous pancreas–kidney transplantation: A single-center cohort study
Lucas Garcias (AR)
Mini-Oral Presentation
11:30
Paired Kidney Analysis of SHK vs KAT: Modest but Meaningful Gain in Dialysis-Free Survival With Kidney-Alone Allocation
Somaya Zahran (US)
11:37
Early clinical outcomes in the first 37 recipients following simultaneous pancreas–kidney transplantation in Denmark after program reinitiation
Christoffer Renault (DK)
11:44
Outcomes following simultaneous liver and kidney transplantation at an Australian single-centre
Maggie Gao (AU)
Room C4.11
Normothermic machine perfusion: Organ assessment, repair, and real-time viability in transplantation
Normothermic machine perfusion: Organ assessment, repair, and real-time viability in transplantation
Chairs
Wayne J. Hawthorne (AU) · Anji Wall (US)
Presentations
Oral Presentation
11:00
A human diseased organ perfusion system for drug evaluation and isolated therapy
Qiang Zhao (CN)
11:10
🎗The “sickest first” principle in the machine perfusion liver transplant era
Vrishketan Sethi (US)
11:20
The Use of a Centralized Normothermic Preservation and Assessment Center to Rescue Kidneys Declined after Standard Allocation
Chris Jaynes (US)
Mini-Oral Presentation
11:30
Preliminary Results from SAFE-NMP Study: Safety Assessment for Extended Normothermic Machine Perfusion in Deceased Donor Kidney Transplantation- A Single Centre Pilot Study
Ashish Sharma (IN)
11:37
Normothermic Machine Perfusion in En Bloc Kidney Transplantation from Infant Donors: Two Innovative Surgical Approaches and Superior Clinical Efficacy
Shuangjin Yu (CN)
Rapid-Fire Presentation
11:44
Innovative Application of Normothermic Machine Perfusion in Kidney Transplantation
Jiang Qiu (CN)
11:49
Restoration of Endothelial BMP9 Signaling During Ex Vivo Lung Perfusion Improves Marginal Donor Lung Recovery
Logan Langerude (US)
11:54
Beyond visible parameters: Deciphering the cellular mechanisms of hepatic early allograft dysfunction following normothermic machine perfusion
Zhixin Liang (CN)
Lunch Break / Industry Symposia / Lunch with Experts & Mentors
Parkside 1&2
Hansa BioPharma Corporate Lunch Symposium on Transplanting the untransplantable – Idefirix® (imlifidase), a breakthrough innovation for highly sensitised kidney transplantation
Hansa BioPharma Corporate Lunch Symposium on Transplanting the untransplantable – Idefirix® (imlifidase), a breakthrough innovation for highly sensitised kidney transplantation
Chair
Steve Chadban (AU)
Organized by
Presentations
12:15
Welcome & Introduction
Steve Chadban (AU)
12:20
Short and long-term outcomes of imlifidase-enabled transplantation: ConfIdeS and beyond
Robert A. Montgomery (US)
12:30
From trials to practice: Real-world experience in France and Europe
Lionel Couzi (FR)
12:40
Bridging evidence into local practice: Case study presentation
Lionel Couzi (FR)
Bridging evidence into local practice: Case study presentation
Peter Hughes (AU)
12:55
Panel discussion and Closing remarks
Steve Chadban (AU)
Pyrmont Theatre Foyer
Lunch and Learn Roundtable
Lunch and Learn Roundtable
Presentations
CMV Guideline
Atul Humar (CA)
Medical Assist in Dying (MAID) and benefit to organ donation
Matthew Weiss (CA)
Survival outcome impact related to distance from transplant center
Susumu Eguchi (JP)
Pediatric cardiovascular health and patient survival
Anette Melk (DE)
Induction and mechanisms of transplant tolerance
Xunrong Luo (CN)
Immunological monitoring of the pancreas graft
Pablo Uva (AR)
Transplant policy, development and education to improve access and quality of kidney transplantation across Latin America
Paola Karina Garcia Padilla (CO)
Infectious disease surveillance and management in clinical xenotransplantation
Jay Fishman (US)
Alternative islet transplant sites
Toby Coates (AU)
Roundtable Mentor
Gabriel E. Gondolesi (US)
Roundtable Mentor
Helen Opdam (AU)
Roundtable Mentor
Dorry Segev (US)
Roundtable Mentor
Fadi Issa (GB)
TTS Connect & Converse Theatre
TTS 60th anniversary
TTS 60th anniversary
Chair
Marcelle McPhaden (CA)
SOTA, Thematic and Concurrent Sessions
Cockle Bay 1
Precision Immune Engineering in Kidney Transplantation
Precision Immune Engineering in Kidney Transplantation
Chairs
Fadi Issa (GB) · Stephen Alexander (AU)
Presentations
13:30
Next-generation co-stimulation blockade
Cheng Yang (CN)
13:52
Regulatory T-cell therapy 2.0: CAR-Tregs
Megan Levings (CA)
14:14
Emerging pharmacotherapies for desensitization in HLA incompatible kidney transplantation
Marta Crespo Barrio (ES)
14:36
How immunosuppressed is my patient: the role of biomarkers in immunosuppression adjustment
Philip O'Connell (AU)
Cockle Bay 2
Bridging Systems, Scaling Access: Asia-Pacific Leadership in Transplantation
Bridging Systems, Scaling Access: Asia-Pacific Leadership in Transplantation
Chairs
Anis Ta'eed (FJ) · Anil Kumar (IN)
Presentations
13:30
From intent to impact: How to start and sustain a deceased donation programme
Maria Gomez (AE)
13:47
Equity and access in fragile health systems: A south asian perspective
Dibya Singh Shah (NP)
14:04
Paired kidney donation at scale: Asian experience driving global dialogue
Pranjal Kashiv (IN)
14:21
From data to action: Asian models of registry-driven transplant policy reform
Jong Cheol Jeong (KR)
14:38
The role of international collaboration in developing transplant programs: A success story from TTS-ILTS paired transplant centers program
Sergelen Orgoi (MN)
Room C3.3
Senotherapy in transplantation
Senotherapy in transplantation
Chairs
Krista Lentine (US) · Jasper Iske (DE)
Presentations
13:30
Aged immune systems drives organ aging
Matthew Yousefzadeh (US)
13:52
Global and local consequences of ‘environmental sciences’ on organ age
Stefan Tullius (US)
14:14
Cell-type and sex specific aspects of senescence
Anette Melk (DE)
14:36
Strategies for senolytic drug discovery
Aaron Schindeler (AU)
Room C3.4-C3.5
How to combat transplant tourism
How to combat transplant tourism
Chairs
Thomas F. Müller (CH) · Benita Padilla (PH)
Presentations
13:30
Patients traveling overseas for transplants - Practical experiences
Anantharaman Vathsala (SG)
13:40
Challenges in registering unethical travel for transplant activities
Dominique Martin (AU)
13:50
The living donor liver registry
Dimitri A. Raptis (SA)
14:00
Tools to detect and report suspicious cases of trafficking
Maria Amalia Matamoros (CR)
14:15
Duty to report – The implementation of mandatory reporting: The UK experience so far
Jessica Porter (GB)
14:30
Panel Discussion
Discussion Period (AU)
Room C3.6
Bridging Transplantation and Regenerative Medicine: Enhancing Graft Viability and Exploring Stem Cell-Islet Immunotherapies in Diabetes
Bridging Transplantation and Regenerative Medicine: Enhancing Graft Viability and Exploring Stem Cell-Islet Immunotherapies in Diabetes
Chairs
Wayne J. Hawthorne (AU) · Thomas Kay (AU)
Presentations
13:30
Pancreas transplantation in type 2 diabetes mellitus
Peter G. Stock (US)
13:47
Diagnosis and treatment of pancreas rejection
Pablo Uva (AR)
14:04
Islets and stem cells in diabetes therapy: Current status
Eelco de Koning (NL)
14:21
Enhancing outcomes with innovative immunosuppressive therapies: Strategies and challenges
Toby Coates (AU)
14:38
Towards immunosuppression-free transplantation: Stem cell-based approaches and immune tolerance
Hanne Scholz (NO)
Room C4.1
The mentorship mosaic: Fostering growth in transplant training and practice
The mentorship mosaic: Fostering growth in transplant training and practice
Chairs
Sarah Tsou (US) · Natasha Rogers (AU)
Presentations
13:30
Introduction and framing / Panel discussant
Fadi Lakkis (US)
Structured Questions for the Panelists
Discussion Period (AU)
Panel discussant
Friederike Martin (DE)
Panel discussant
Gomathy Narasimhan (IN)
Panelist
Angela Webster (AU)
Panelist
Karen Dwyer (AU)
Panel discussant
Shruti Tapiawala (IN)
Q&A questions from the audience
Discussion Period (AU)
13:50
Closing remarks
Natasha Rogers (AU)
Room C4.4
Minimal Invasive Transplantation
Minimal Invasive Transplantation
Chairs
Susumu Eguchi (JP) · Emily Granger (AU)
Presentations
13:30
Minimally invasive thoracic organ transplantation
Albert Jauregui (ES)
13:52
Minimally invasive abdominal organ transplantation
Kwang Woong Lee (KR)
14:14
Education and training strategies to safely disseminate robotic organ transplantation
Jinna Yao (AU)
14:36
Future technological development in robotic organ transplantation
Dieter Broering (SA)
Room C4.5
Using Technology to optimize outcomes of Liver Transplantation
Using Technology to optimize outcomes of Liver Transplantation
Presentations
13:30
Normothermic regional perfusion: Is ex vivo perfusion still necessary?
Anji Wall (US)
13:52
What does optimal use of HOPE and NMP look like?
Carlo Pulitano (AU)
14:14
Ischemia-free organ transplantation
Zhiyong Guo (CN)
14:36
The future for artificial Intelligence in liver transplant
Dorry Segev (US)
Room C4.6
Advancing Uterus Transplantation: Global Practices, Innovations, and Program Development
Advancing Uterus Transplantation: Global Practices, Innovations, and Program Development
Chairs
Jiri Fronek (CZ) · Limor Meoded Danon (IL)
Presentations
13:30
Global uterus transplantation activities and outcomes: the ISUTx registry
Mats Brännström (SE)
13:52
Robotic surgery in uterus transplantation
Jean-Marc Ayoubi (FR)
14:14
Setting up a uterus transplantation program
Rebecca Deans (AU)
14:36
Updates on treatment and donor/recipient selection
Paige Porrett (US)
Room C4.7
Innovating the Pathway: Allied Health Contributions to Advancing Organ Donation and Transplantation
Innovating the Pathway: Allied Health Contributions to Advancing Organ Donation and Transplantation
Chairs
Anne Floden (SE) · Bronwyn Levvey (AU)
Presentations
13:30
Driving excellence in transplant care: The role, vision and impact of the tts allied health committee
Estephan Arredondo (ES)
13:45
Extending organ viability: The role of allied health in machine perfusion programs
Joaquim Albiol (ES)
14:00
Mobilizing recovery: Physiotherapy as a key player in the transplant continuum
Louise Fuller (AU)
14:15
Strategies to improve adherence after solid organ transplantation
Mariel Nöhre (DE)
14:30
Panel Discussion
Discussion Period (AU)
Panel discussion
Bronwyn Levvey (AU)
Room C4.8
Donor Evaluation and Optimization: Bridging Safety and Organ Utilization
Donor Evaluation and Optimization: Bridging Safety and Organ Utilization
Chairs
Tina Marinelli (AU) · Atul Humar (CA)
Presentations
13:30
mNGS and rapid diagnostics: The next frontier in donor screening?
Maricar Malinis (US)
13:52
HIV-positive organ donation: Evolving guidelines and global perspectives
Cameron R. Wolfe (US)
14:14
MDRO: Cross-disciplinary approaches to donor-derived infection risk assessment
Priscilla Rupali (IN)
14:36
Donors in the tropics and LMICs: What to consider?
Siriorn Watcharananan (TH)
Room C4.9
Building high-performing transplant registries: Global consensus recommendations and a practical maturity framework
Building high-performing transplant registries: Global consensus recommendations and a practical maturity framework
Chair
Sang Joseph Kim (CA)
Presentations
13:30
Opening remarks and overview: From fragmented data to global alignment. Why transplant registries need a shared framework
Sang Joseph Kim (CA)
13:40
Creating a transplant registry: Defining purpose, scope, and sustainable infrastructure
Germaine Wong (AU)
13:50
Establishing trust: Governance, ethics, and legal architecture of transplant registries
Axel Rahmel (DE)
14:00
Designing registries that work: Data architecture, harmonization, and operational feasibility
Jon Snyder (US)
14:10
Using registry data responsibly: Methodology, bias mitigation, and meaningful interpretation
Allan Massie (US)
14:20
From aspirational standards to practical assessment: Introducing the transplant registry maturity model
Yee Lu (US)
14:30
Panel Discussion
Discussion Period (AU)
Panelist
Nicole Jane Scholes-Robertson (AU)
Room C4.11
Harnessing the Power of Genetics in Pediatric Transplantation
Harnessing the Power of Genetics in Pediatric Transplantation
Chairs
Siah Kim (AU) · Carl Grabitz (DE)
Presentations
13:30
Overview of genomic sequencing techniques
Katherine E. Twombley (US)
14:00
When and why to consider genetic testing pre-transplant
Hugh McCarthy (AU)
14:30
Bioethics in transplant gene testing
Anne Priesz (AU)
Coffee Break / Exhibits and Poster Viewing
Hall 1-2
Coffee Break
Coffee Break
No lectures assigned yet.
TTS Connect & Converse Theatre
Meet with the Transplantation Editors
Meet with the Transplantation Editors
Chair
Carolyn Sidoti (US)
Presentations
Transplantation Editor-in-Chief
Stefan Tullius (US)
Transplantation Executive Editors
Edward Geissler (DE)
Afternoon Abstract and Concurrent Sessions
Cockle Bay 1
Transplant candidate determinants of post-transplant outcomes
Transplant candidate determinants of post-transplant outcomes
Chairs
Steve Chadban (AU) · Sadia Jahan (AU)
Presentations
Oral Presentation
15:30
It’s about time: A target trial emulation of preemptive vs. non-preemptive kidney transplantation
Sang Joseph Kim (CA)
15:40
Mental Illness and Post-Transplant Outcomes in Kidney Transplant Recipients: A Population-Based Cohort Study
Melanie Wyld (AU)
Mini-Oral Presentation
15:50
CARSK trial baseline characteristics and generalisability
Steve Chadban (AU)
15:57
Age-dependent differences in pediatric versus adult kidney transplantation: Impaired VEGF and NO signaling weaken microvascular integrity and threaten renal graft survival
Alev Ok Atılgan (TR)
Rapid-Fire Presentation
16:04
Renal Dysfunction as an Independent Risk Factor for Pneumocystis jirovecii Pneumonia in Immunosuppressed Patients: A Systematic Review and Meta-Analysis
Dong Hwan Jung (KR)
16:09
Frailty assessment in kidney transplantation: A practice-perception gap in Australia and New Zealand
Amy Barnett (AU)
16:14
🎗Patterns and trends in kidney transplantation among women in adult nephrology practice
Nishtha Manuja (IN)
Cockle Bay 2
Omics in transplantation 1
Omics in transplantation 1
Chairs
Ana Konvalinka (CA) · Carol Pollock (AU)
Presentations
Oral Presentation
15:30
🎗Lipid-associated macrophage polarization and APOE–SDC2 signaling underlies chronic xenograft fibrosis
Minhee Seong (KR)
15:40
Quantitative Urine Proteomics Distinguishes Kidney Transplant Rejection from Normal Allograft Pathology
Stephanie Kuo (AU)
15:50
MALDI imaging mass spectrometry reveals systemic and airway IgG glycan signatures associated with Primary Graft Dysfunction after lung transplantation
Hassan Moussa (US)
16:00
EVLP Reprograms Donor Lung Transcriptomics and Attenuates Donor-Specific Immune Signatures
Irene Bello (ES)
Room C3.3
Cancer, co-morbidities and kidney transplant outcomes
Cancer, co-morbidities and kidney transplant outcomes
Chairs
Angela Webster (AU) · Wai Lim (AU)
Presentations
Oral Presentation
15:30
🎗Transplantation and mortality as competing outcomes among patients on dialysis with newly diagnosed cancer – a longitudinal cohort study
Ryan Gately (AU)
15:40
Expanding the Donor Pool: Multicentric Outcomes of Kidney Transplantation from Donors with Small Renal Tumors A Collaborative Study Across Seven European Centers
Mireia Musquera (ES)
Mini-Oral Presentation
15:50
Cancer screening participation in solid organ transplant recipients: a scoping review
Nida Saleem (AU)
15:57
Renal artery embolization to enable transplantation in Polycystic kidney disease: A UK tertiary centre experience
Adithi Shankar (GB)
Rapid-Fire Presentation
16:04
Cancer stage and treatment patterns in kidney transplant recipients compared with non-transplant patients in a multicenter hospital tumor registry
Laia Oliveras (ES)
16:10
Clinical impact of donor kidney volume–Recipient body size mismatch on kidney transplant outcomes
Shunta Hori (JP)
16:15
Development and validation of a novel nomogram model for predicting delayed graft function in deceased donor kidney transplantation based on pre-transplant biopsies
Meihe Li (CN)
16:20
Post-Transplant Anemia and Graft Outcomes in 9,472 Kidney Transplant Recipients: Graft Loss Risk Is Amplified at Preserved Renal Function
Minyu Kang (KR)
Room C3.4-C3.5
Insights into old and new therapeutics 1
Insights into old and new therapeutics 1
Chairs
James Lan (CA) · Raman Venkataramanan (US)
Presentations
Oral Presentation
15:30
Senolytic treatment during normothermic machine perfusion dampens ischemia reperfusion injury in old livers
Jasper Iske (DE)
15:40
🎗IgA Specific TCR Engineered T Cells as a Precision Cellular Therapy for IgA-Mediated Kidney Disease in Transplantation
Merve Bilici (GB)
15:50
TESP-0401 improves delayed graft function in a kidney transplantation mouse model
Nicola Giacche (IT)
16:00
🎗Functional Investigation of Induced Tregs Generated via Locus-Specific Epigenome Reprogramming of Effector T Cells
Audrey Au Yong (GB)
Mini-Oral Presentation
16:10
Pre-sensitization disrupts transplant tolerance by driving PD1⁺ regulatory T cells with impaired function in an inflammatory microenvironment.
Qiang Zhang (CN)
16:17
Transplant tolerance to cardiac allografts induced in neonatal mice with allogeneic neonatal liver and thymic cells
Lori J. West (CA)
Room C3.6
Advancing ABO histocompatibility: Needs and solutions
Advancing ABO histocompatibility: Needs and solutions
Chairs
Janette Kwok (HK) · Lucy Sullivan (AU)
Presentations
15:30
ABO antigens and antibodies: Updating old dogmas
Anne Halpin (CA)
15:50
Beyond HLA: Adaptive sequencing for blood group profiling in transplantation
Karen Sherwood (CA)
16:10
ABO incompatible kidney transplantation, strategies and successes
Marta Crespo Barrio (ES)
Room C4.1
Surgical innovation and complex vascular reconstruction in liver transplantation
Surgical innovation and complex vascular reconstruction in liver transplantation
Presentations
Oral Presentation
15:30
Learning-Curve Analysis of Robotic Recipient Liver Transplantation
Dieter Broering (SA)
Mini-Oral Presentation
15:40
Deep Learning-Based Quantitative Intraoperative ICG Fluorescence Analysis Predicts Biliary Stricture After Living Donor Liver Transplantation
Yuyoung Oh (KR)
15:47
Comparative Effectiveness of Technical Variants in Pediatric Liver Transplantation: A Network Meta-Analysis
Isabella Faria (US)
Rapid-Fire Presentation
15:54
Is remnant liver volume <30% an absolute contraindication in purely laparoscopic living donor hepatectomy?
Sukmin Gwon (KR)
15:59
The use of a modified great saphenous vein for hepatic vein reconstruction in right lobe living donor liver transplantation
Bolatbek Baimakhanov (KZ)
16:04
Synthetic Vascular Grafts for Middle Hepatic Vein Tributary Reconstruction Enhance Liver Regeneration in Right Lobe Living Donor Liver Transplantation
Hidenobu Kojima (JP)
16:09
Estimation of whole and left lateral segment volume using donor weight in paediatric liver transplant - how accurate do we get?
Mansha Jiwane (AU)
16:14
First clinical application of auxiliary partial orthotopic liver transplantation (APOLT) for blunt hepatic trauma – a two-case report
Lukasz Masior (PL)
16:19
Influence of splenic artery ligation on portal and arterial adaptation of the graft after living donor right lobe liver transplantation according to MSCT
Rukhsora Sultonova (UZ)
Room C4.2
Expanding donor access: The impact of ECMO in thoracic transplantation a TTS/ISHLT Conjunct Session
Expanding donor access: The impact of ECMO in thoracic transplantation a TTS/ISHLT Conjunct Session
Chairs
Pablo Sanchez (US) · Raj Ramanan (US)
Presentations
15:30
ECPR-driven growth in the donor pool
Alvaro Perazzo (BR)
15:45
Diagnosing brain death in the ECMO patient
Kavitha Muthiah (AU)
16:00
The role of NRP and machine perfusion in cardiothoracic transplantation
Sandra Lindstedt (SE)
16:15
Complex decisions: Ethical dilemmas of ECMO, DCD and NRP donors
Emily Granger (AU)
Room C4.4
From patient to planet: The global essential standards as a framework for transformative change in transplantation
From patient to planet: The global essential standards as a framework for transformative change in transplantation
Chair
John J. Fung (US)
Presentations
15:30
The human face of standards
John J. Fung (US)
15:35
From principles to practice: Protecting dignity, trust and equity in transplantation
John J. Fung (US)
Nothing about us without us: Making patients and families partners in transplantation
Karen Rockell (GB)
16:00
The institutional blueprint: How the global essential standards create a transplant ecosystem that is equitable, safe, and self-sustaining
Medhat Askar (US)
16:25
Stakeholders perspective from China: Translating standards into value for every actor in the ecosystem
Haibo Wang (CN)
16:35
Stakeholders perspective from Australia: Translating standards into value for every actor in the ecosystem
Helen Opdam (AU)
16:45
Connecting the circles: Panel discussions
Discussion Period (AU)
Room C4.5
Tumor biology and immunotherapy in liver transplantation for hepatocellular carcinoma
Tumor biology and immunotherapy in liver transplantation for hepatocellular carcinoma
Chairs
Nancy Kwan Man (HK) · Takashi Ito (JP)
Presentations
Oral Presentation
15:30
🎗Characterization of CCR8+ Regulatory T Cells as a Key Driver of Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma
Ruidong Ding (CN)
15:40
🎗A novel retinoic acid receptor-related orphan receptor gamma inverse agonist enhances immune checkpoint inhibitor response in hepatocellular carcinoma to potentially expand liver transplant eligibility
Sabrina Leo (CA)
15:50
Tumor-lysate pulsed dendritic cell as a supplement treatment for post-transplant hepatocellular carcinoma recurrence
Wei-Chen Lee (TW)
16:00
Downstaging strategies for HCC within the AFP score allocation system: a tale of two trajectories
Catherine Lamarque (FR)
Mini-Oral Presentation
16:10
Liver-lung communication of cirrhosis-derived CHI3L1 drives hepatocellular carcinoma metastasis after liver transplantation
Huigang Li (CN)
16:17
Sirolimus-elicited gammadelta T cell response attenuates pulmonary metastasis in hepatocellular carcinoma
Jianyong Zhuo (CN)
16:24
Characterization of Extrachromosomal DNA Profiles in Post-Transplant Hepatocellular Carcinoma: A Exploratory Study
Su Young Hong (KR)
Room C4.6
Ethical and legal lenses of organ donation and allocation
Ethical and legal lenses of organ donation and allocation
Presentations
Oral Presentation
15:30
Legal, ethical and logistic challenges during prolonged somatic support of a pregnant woman after neurologic determination of death
Matthew Weiss (CA)
15:40
A Bolder and Braver approach to deceased organ donation in the UK
Dale Gardiner (GB)
Mini-Oral Presentation
15:50
Factors contributing to allocation out-of-sequence for kidneys and livers in the United States
Carrie Thiessen (US)
15:57
Professional ethical reasoning in nursing during the DCD process: A comparative study from Sweden and Spain
Anne Floden (SE)
16:04
From Framework to Practice: Implementing Ethical Safeguards for Donation after Assisted Dying in Aotearoa New Zealand
Kim Grayson (NZ)
Rapid-Fire Presentation
16:11
The 5th Pou (Pillar): Embedding Te Tiriti (Treaty of Waitangi) in Assisted Dying and Donation — An Evolving Approach in Aotearoa New Zealand
Kim Grayson (NZ)
16:16
Requesting life through the voice of a mediator: A psychosocial study of the effect of mediation in requesting donations between relatives of patients with liver and kidney failure
Yaser Kattoah (SA)
16:21
Breaking the Silence: Implementing a Black led peer support partnership to improve access to living donor kidney transplantation for Black patients
Sumoyee Basu (GB)
Room C4.7
Quality and safety in organ donation and transplant care
Quality and safety in organ donation and transplant care
Chairs
Lisa A. Coscia (US) · Helen L. Pilmore (NZ)
Presentations
Oral Presentation
15:30
Prioritisation of kidney transplant systematic review and guideline topics: a modified Delphi study
David Tunnicliffe (AU)
15:40
The HOUSES Index directly predicts cumulative hospitalization risk after kidney transplantation.
Somaya Zahran (US)
Mini-Oral Presentation
15:50
A dynamic interdisciplinary collaboration model between organ procurement organization and transplantation specialties improves deceased donor organ quality metrics the China experience
Guozhen Chen (CN)
15:57
Improving Reproductive Risk Screening and Mycophenolate Risk Evaluation and Mitigation Strategy Compliance Through a Standardized Kidney Transplant Workflow
Silvi Shah (US)
16:04
Integrating palliative and supportive care in heart and lung transplantation: phase 1 of a quality improvement initiative for a hybrid service model
Shampa Sinha (AU)
16:11
Organ donation after medical assistance in dying: Evidence on transplant outcomes and system impact
Vanessa Silva e Silva (CA)
Rapid-Fire Presentation
16:18
A Delphi study to establish consensus on the nutritional management in pre- and post-kidney transplantation
Arian Chong (AU)
16:23
Mozart music intervention contributes to the psychological benefits and immunological recovery in perioperative period after solid organ transplant surgery: a prospective randomized controlled trial
Baoren Tu (CN)
Room C4.8
Infectious complications in solid organ transplantation
Infectious complications in solid organ transplantation
Presentations
Oral Presentation
15:30
Integrating Clinical and immune response Biomarkers to Understand kidney Graft recipient’s risk of infection (the IC-BUG study)
Matthew Rowlandson (AU)
Mini-Oral Presentation
15:40
From exclusion to opportunity: Rethinking contraindications in organ donation. A 5-Year UAE analysis
Reginaldo Boni (AE)
15:47
Multidrug-resistant donor-derived infections in solid organ transplantation: a systematic review and meta-analysis of transmission risk factors
Carolina Lopes (BR)
15:54
Invasive fungal infections in heart transplants: A ten-year, single centre experience from subtropical Australia
Kanthi Vemuri (AU)
16:01
10-year cohort of donor-derived disease in solid organ transplantation in Germany from 2016-2025
Ana Paula Barreiros (DE)
16:08
Evaluation of empiric intraoperative antibiotic regimens for coverage of donor-derived infection in lung transplantation: A single-center retrospective study
Zhenyu Zhang (CN)
16:15
Identification and validation of clinical phenotypes in liver transplant donors and recipients to predict early mortality and infections
Cecilia Bonazzetti (IT)
Rapid-Fire Presentation
16:22
Legionella pneumonia: Comparison between solid organ transplant and hematopoietic stem cell transplant recipients
Holenarasipur Vikram (US)
16:28
High burden of tuberculosis and invasive fungal infections after heart transplantation in TB-endemic setting: a 20-year cohort from Thailand
Pakpoom Phoompoung (TH)
16:34
When CMV mismatch meets demographics: CMV donor/recipient serostatus and mortality after liver transplantation
Maheen Abidi (US)
16:40
EBV mismatch in kidney transplantation: rates of viraemia, seroconversion and post-transplant lymphoproliferative disorder
Janine Miranda (NZ)
Room C4.9
Clinical pharmacology
Clinical pharmacology
Chairs
Teun van Gelder (NL) · Steven Ivulich (AU)
Presentations
Oral Presentation
Kidney allograft donor ABCB1 pharmacogenotype predicts long term vascular fibrous thickening and tubular atrophy – pharmacogenomic analysis of a prospective Australian cohort
Joshua Lawrence Lee (AU)
Mini-Oral Presentation
Clinical significance of intra-patient tacrolimus variability and tacrolimus exposure in older kidney transplant recipients
Minyu Kang (KR)
Mechanism study of Tacrolimus inhibiting FXR mediated toxicity of renal tubular epithelial cells
Zhaofeng Liu (CN)
BAP-Tac (BuccomucoAdhesive Patch-based Tacrolimus) Delivery System: The Next-Generation of Tacrolimus Administration
Smita Pattanaik (IN)
Hidden Interaction: Dulaglutide Significantly Alters Immunosuppressant Pharmacokinetics After Kidney Transplantation
Nuria Montero (ES)
Early Post-Transplant Torque Teno Virus (TTV) Load Dynamics Predict Infection Risk and Reflect Immune Alterations in Kidney Transplant Recipients
Tarun Kumar (IN)
Room C4.10
Education to outcomes: Enhancing organ donation through training, technology, and public insight
Education to outcomes: Enhancing organ donation through training, technology, and public insight
Chairs
Ala Ali (IQ) · Susu Zughaier (QA)
Presentations
Oral Presentation
15:30
The Mighty Method™: A Structured Pedagogical System for Scalable, Evidence-Informed Organ Donation Education in Children
Roydon Turner (GB)
15:40
The status quo of transplant surgeon training and certification system in China
Jie Zhao (CN)
Mini-Oral Presentation
15:50
Development and application of an intelligent agent training platform for organ donation coordinators based on the five habits communication framework
Baoren Tu (CN)
15:57
The Mighty Engine: A Traveling Museum Exhibit Advancing Early Health Literacy and Organ Donation Awareness Through Experiential Learning
Peggy John (CA)
16:04
Patient Satisfaction and Self-Rated Health After Kidney Transplantation in Vietnam: Are Subjective Outcomes Aligned with Clinical Status?
Hien Nguyen (VN)
16:11
Revolutionizing organ donor evaluation: A reproducible clinical framework for potential donor evaluation. UAE Results - 5 years experience
Reginaldo Boni (AE)
Rapid-Fire Presentation
16:18
Resilience mediates the association between social support and job burnout among organ donation coordinators in China: A national cross-sectional study
Cuiyu Zhong (CN)
16:23
Transforming public engagement in organ donation: the Impact of the world’s first organ donation and transplantation museum
Ernesto Duarte-Tagles (MX)
Room C4.11
Transplant outcomes and donor biology in the context of multiorgan and regenerative transplant innovation
Transplant outcomes and donor biology in the context of multiorgan and regenerative transplant innovation
Chairs
Elias David-Neto (BR) · Akihiko Soyama (JP)
Presentations
Oral Presentation
15:30
Outcomes of Kidney Transplantation From Organ Donation After Medical Assistance in Dying (MAiD): The University Health Network Experience
Angel Ngo (CA)
15:40
One-year survival and function of allogeneic beta-cells with no immunosuppression
Xiaomeng Hu (US)
Mini-Oral Presentation
15:50
Donor outcomes in living donor liver transplantation for acute liver failure – a prospective cohort study from the International LDLT Registry
Marina Berenguer (ES)
15:57
Multimodal Baseline Renal Function Assessment Improves Prediction of One-Year eGFR After Living Kidney Donation
Rehan Ansari (US)
Rapid-Fire Presentation
16:04
First In human Successful CRISPR/Cas9 Gene Therapy (Exagamglogene Autotemcel) in a Heart Transplant Recipient with Beta-Thalassemia Major
Rabi Hanna (US)
16:09
Understanding the Relationship Between Pre-Implantation Kidney Allograft Biopsies and Early Transplant Outcomes: Insights from a Canadian Transplant Centre
Sang Joseph Kim (CA)
16:14
Allogeneic transplantation of human induced pluripotent stem cell-derived islet cells in a patient with type 1 diabetes
Kei Yamane (JP)
16:19
Non-invasive assessment of steatosis in living liver donors: Correlation of shear wave elastography and blood cholesterol with histology
Erdenebileg Bavuujav (MN)
Workshop Sessions / Industry Symposium / Poster Sessions
Cockle Bay 1
Sex, cancer, and the graft: What women need most from transplant care
Sex, cancer, and the graft: What women need most from transplant care
Chairs
Karen Keung (AU) · Nazia Selzner (CA)
Presentations
16:45
Do women do better or worse – What the data say across cancer and transplant?
Brenda Maria Rosales (AU)
17:03
From association to causation: Sex, cancer and transplant outcomes
Craig Coorey (AU)
17:21
Screening, hormones, and birth plans: a playbook for female recipients
Sakhee Kotecha (AU)
17:39
Post transplant care: Patient perspectives
Nicole Jane Scholes-Robertson (AU)
Room C3.3
Optimizing cardiometabolic health across the lifespan following transplantation
Optimizing cardiometabolic health across the lifespan following transplantation
Presentations
16:45
Introduction
Karen Dwyer (AU)
Introduction
Amanda Sluiter (AU)
16:48
Panelist
Nuria Montero (ES)
16:51
Panelist
Zhejia Tian (DE)
16:54
Panelists
Maria Simonenko (RU)
16:57
Panelist
Penny Figtree (AU)
17:00
Panelist
Emma Tumilty (AU)
17:03
Panelist
John Lafferty (AU)
17:06
Panelist
Patricia Scheetz (AU)
17:09
Moderator/Panelist
Karen Dwyer (AU)
Moderator/Panelist
Brenda Maria Rosales (AU)
Moderator/Panelist
Amanda Sluiter (AU)
17:50
Closing discussion
Karen Dwyer (AU)
Room C3.4-C3.5
Transplant without borders: Collaborative solutions for global kidney care
Transplant without borders: Collaborative solutions for global kidney care
Chairs
Germaine Wong (AU) · Medhat Askar (US)
Presentations
16:45
The global interdependence of health and the burden of kidney disease as a pressing public health priority
Benita Padilla (PH)
17:03
Transplant knowledge and skills transfer: the role of collaborative partnerships in reducing disparities in kidney disease-related morbidity and mortality
Shyam Bihari Bansal (IN)
17:21
Overcoming the challenges in achieving equity in global access to kidney transplantation
Beatriz Domínguez-Gil (ES)
17:39
Sustainable and scalable models for establishing kidney transplant programs in resource-limited contexts
John S. Gill (CA)
Hall 1-2
Poster Session 1
Poster Session 1
Cockle Bay 2
Expanding the living donor pool in kidney transplantation: Insights from Indian experience
Expanding the living donor pool in kidney transplantation: Insights from Indian experience
Chairs
Manish Mali (IN) · Anurag Gupta (IN)
The session is supported by an educational grant from
Presentations
17:00
ABO-incompatible kidney transplantation- breaking the blood group barriers
Raj Kumar Sharma (IN)
17:10
Beyond compatibility: Managing highly sensitized kidney transplant recipients
Shruti Tapiawala (IN)
Networking Events
Cockle Bay 1
Women in Transplantation Networking Reception
Women in Transplantation Networking Reception
Pumphouse
Early-Career Networking Event
Early-Career Networking Event
Tuesday, September 22, 2026
Offsite
TTS Congress Fun Run & Walk - IMEX at Palm Grove
TTS Congress Fun Run & Walk - IMEX at Palm Grove
No lectures assigned yet.
Parkside 1&2
Bridge to Life Corporate Breakfast Symposium on Scaling better outcomes: The role of HOPE in contemporary transplant programs
Bridge to Life Corporate Breakfast Symposium on Scaling better outcomes: The role of HOPE in contemporary transplant programs
Chair
Don Webber (US)
Organized by
Presentations
07:00
Opening remarks
Don Webber (US)
07:05
HOPE in contemporary clinical practice: Workflow, latest data, and outcome trends
Anji Wall (US)
07:20
Viability assessment: Current approaches and evolving standards
Andrea Schlegel (US)
07:35
Extended applications of HOPE beyond standard use: Pediatric, living donor, surgical, multivisceral, and intestinal applications
Francisco Hernández Oliveros (ES)
07:50
Discussion and closing remarks
Don Webber (US)
Morning Abstract and Concurrent Sessions
Cockle Bay 1
Prediction of kidney transplant outcomes
Prediction of kidney transplant outcomes
Chairs
Tracey Ying (AU) · Vikas Sridhar (CA)
Presentations
Oral Presentation
08:00
A dynamic prediction model for transplant renal artery stenosis based on donor atherosclerotic lesions at the renal artery ostium
Yiling Fang (CN)
Mini-Oral Presentation
08:10
Impact of baseline isoagglutinin titer on outcomes in ABO-incompatible kidney transplantation: a French multicenter study
Lionel Couzi (FR)
08:17
Prognostic significance of early donor-derived cell-free DNA elevations after kidney transplantation
Didier Mandelbrot (US)
08:24
The impact of the type of post-transplant thrombotic microangiopathy on graft and patient outcomes
Ekaterina Ivanova (RU)
08:31
Performance of Computable Phenotypes for Identification of Immunosuppression Related Complications in Kidney Transplant Recipients within the Patient-Centered Clinical Research Network
Vikas Dharnidharka (US)
08:38
Molecular HLA matching as predictive factors for graft and patient outcomes in kidney transplantation: a systematic review
Kristy Nguyen (AU)
Rapid-Fire Presentation
08:45
The Canadian Highly Sensitized Patient (HSP) program: post–deceased donor kidney transplant survival comparable to national benchmarks
Michel Paquet (CA)
08:50
Mediation analysis of delayed graft function and graft loss in kidney transplant recipients
Dharshana Sabanayagam (AU)
08:55
Short-term PM2.5 Exposure and Hospital Readmission After Kidney Transplantation: A Nationwide Time-Stratified Case-Crossover Study
Ting Lu (US)
Cockle Bay 2
Omics in transplantation 2
Omics in transplantation 2
Chairs
Andrea Schlegel (US) · Ana Konvalinka (CA)
Presentations
Oral Presentation
08:00
Integrating radiomics and spatial transcriptomics for predicting hepatocellular carcinoma post-transplant recurrence and deciphering the metastatic-permissive spatial niche
Zhikai Jiang (CN)
08:10
Spatial single-cell mapping of liver allograft inflammation reveals distinct immune microenvironments
Timucin Taner (US)
08:20
Ccl5⁺ Macrophages Orchestrate Immunometabolic Interaction in Cardiac Allograft Rejection via Integrated Multi-Omics
Quan Zhuang (CN)
Mini-Oral Presentation
08:30
Temporospatial profiling reveals three-way T cell chimerism and alloreactivity in a patient receiving a second intestinal transplant
Jianing Fu (US)
08:37
Comparative Analysis of Outcomes and Perfusate Proteomics from a High-Volume U.S. Center
Tiffany Lim (US)
08:44
Defining the Immune-Metabolic Landscape of Aged Allografts: Insights from Metabolomic Profiling in Acute Heart Transplant Rejection
Sarah Tsou (US)
Room C3.3
Mechanisms and management of AMR in kidney transplant recipients
Mechanisms and management of AMR in kidney transplant recipients
Presentations
Oral Presentation
08:00
Prolonged CD38 targeting with felzartamab achieves sustained suppression of antibody-mediated rejection in kidney transplant recipients: a biomarker-guided open-label phase 2 extension
Katharina Mayer (AT)
08:10
Unbiased and Spatial Proteomics of Kidney Allograft Biopsies: Terminal Complement Proteins Dominate Chronic Active Antibody Mediated Rejection
Maya Allen (CA)
Mini-Oral Presentation
08:20
HLA Eplet-based risk stratification for DSA and ABMR after kidney transplantation with validation of immunogenicity and immunoreactivity
Zhou Guxiang (CN)
08:27
Tissue effector signatures define distinct mechanistic phenotypes of microvascular inflammation and predict kidney allograft outcomes beyond DSA and C4d
Alev Ok Atılgan (TR)
Rapid-Fire Presentation
08:34
Novel IgG-Degrading Enzyme Therapy for the Desensitization in Highly HLA-sensitized Kidney Transplant Recipients: A Phase 2 Study
Yongbo Wang (CN)
08:39
Characteristics of non-HLA antibodies in patients after kidney transplantation and their association with renal allograft pathological status
Meihe Li (CN)
08:44
Extracorporeal photopheresis for antibody-mediated rejection in kidney transplant recipients at high risk of infection: A case series
Nikolina Basic-Jukic (HR)
Room C3.4-C3.5
Immunoregulation: Tolerance versus rejection 1
Immunoregulation: Tolerance versus rejection 1
Chairs
Alexandra Sharland (AU) · Andrea Bähr (DE)
Presentations
Oral Presentation
08:00
Microplastic Exposure Accelerates Graft Loss in a Murine Chronic Cardiac Allograft Rejection Model
Quan Zhuang (CN)
08:10
Donor γδ T cells promote blood chimerism while recipient γδ T cells contribute to graft rejection after human intestinal transplantation
Bing Chen (CN)
Mini-Oral Presentation
08:20
CD300a Regulates T Cell Function to Promote Allogeneic Cardiac Graft Survival
Helong Dai (CN)
08:27
Single-cell multi-omics characterization of rejection in transplanted kidneys reveals key cell types and a regulator of chronic rejection
Bingxuan Zheng (CN)
08:34
Leucine attenuates allograft rejection by reversing memory-like NK cell responses via subset redistribution
Jifu Ge (CN)
08:41
🎗Longitudinal dd-cfDNA Dynamics Enable Early Detection of Acute Rejection in Pediatric Liver Transplant Recipients
Agostina Arrigone (AR)
08:48
Chronic lung allograft dysfunction phenotype is associated with recipient KIR genotypes
Samuel Robinson (AU)
Room C3.6
Emerging challenges in transplantation: Allocation, risk prediction, and long-term outcomes
Emerging challenges in transplantation: Allocation, risk prediction, and long-term outcomes
Chairs
Lachlan McMichael (AU) · Ross Francis (AU)
Presentations
Oral Presentation
08:00
The rate of glomerulosclerosis as an appropriate criterion for allocation of marginal kidneys into single or dual kidney transplantation
Jia Sheng Xie (CN)
08:10
Body-composition abnormalities and post-transplant prognosis in hepatocellular carcinoma liver transplantation: a multi-task clinical surrogate model
Jinyan Chen (CN)
08:20
Initial kidney graft function and its association with short- and long-term graft outcomes: a paired kidney analysis
Wai Lim (AU)
08:30
Development of a Machine Learning Model to Predict 90-Day Mortality Risk After Deceased-Donor Kidney Transplantation
Sergio Salcedo Herrera (CO)
08:40
Liver transplantation disparties by ABO blood type in the machine perfusion era
Elizabeth Swanson (US)
Room C4.1
Delivering value in liver transplantation: Innovation, resources, and the future of care
Delivering value in liver transplantation: Innovation, resources, and the future of care
Presentations
08:00
Implementing change and managing resources: Can we do both?
Alfred Kow (SG)
08:20
Defining value in liver transplantation: Focusing on what matters
Julie K. Heimbach (US)
08:40
Telemedicine and remote monitoring: the potential of digital health tools to optimise patient care
Brooke Huuskes (AU)
Room C4.5
Long-term outcomes and risk stratification after liver transplantation
Long-term outcomes and risk stratification after liver transplantation
Presentations
Oral Presentation
08:00
Saroglitazar improves post-liver transplant metabolic associated steatotic liver disease- A randomized controlled trial- interim analysis
Dinesh Jothimani (IN)
Mini-Oral Presentation
08:10
Harnessing the estrogen-PARP axis: A key to enhancing liver graft survival and combating fibrosis
Binnaz Handan Ozdemir (TR)
08:17
Early Post-Transplant Recipient-Derived Cell-Free DNA Predicts One-Year Graft Survival in Liver Transplant Recipients
Eun-Ki Min (KR)
08:24
25 years of pregnancy outcomes after liver transplantation
Lisa A. Coscia (US)
08:31
Temporal changes in graft failure over three decades of liver transplantation: Insights from ultra-long-term outcomes with well-maintained follow-up at a single center
Masaaki Hirata (JP)
Rapid-Fire Presentation
08:38
Post-transplant MASLD does not adversely affect long-term survival or cardiometabolic outcomes following liver transplantation
Ki Sang Jung (KR)
08:43
Liver Transplantation After TARE Downstaging in Advanced Hepatocellular Carcinoma: A Single-Center Experience
Dahyun Jung (KR)
08:48
A 25-year experience of a “free of cost” dedicated living donor clinic in a low-middle-income countries. An insight into impediments to compliance in regular yearly follow-up and their impact on long-term outcomes
Mirza Zafar (PK)
Room C4.6
Expanding transplant access: Innovations in training, simulation, and global collaboration
Expanding transplant access: Innovations in training, simulation, and global collaboration
Chairs
Jen Li (AU) · Marti Manyalich Vidal (ES)
Presentations
Oral Presentation
08:00
World’s First Heart to Heart Exchange: Connecting Children in Canada and South Africa Through Organs, Habits and Kindness
Peggy John (CA)
Co-Presenting: World’s First Heart to Heart Exchange: Connecting Children in Canada and South Africa Through Organs, Habits and Kindness
David Thomson (ZA)
08:13
🎗Barriers to Kidney Transplantation Among Dialysis Patients in a Low-Middle Income Country: A Large Patient-Reported Survey
Ruchir Dave (IN)
Mini-Oral Presentation
08:23
MNGIE: Largest single-center experience of a comprehensive multidisciplinary clinic and diverse therapeutic methodologies
Ehab Abufarhaneh (CA)
08:30
SimU-Skin: A 4D Tactile Simulation Platform to Improve Patient Recognition of Sentinel Skin Flap Changes Following Solid Organ Transplantation
Omar Quidwai (IE)
08:37
Fellowship training and the learning curve in living donor kidney transplantation in a low-resource setting: early experience from Rwanda
Alexandre Nyirimodoka (RW)
08:44
Strengthening organ donation systems through workforce capacity building: Implementation evaluation of the essential skills in organ donation training program
Amal AlFar (AE)
Room C4.7
Optimizing pancreas and islet transplantation: From donor selection and graft preservation to functional outcomes
Optimizing pancreas and islet transplantation: From donor selection and graft preservation to functional outcomes
Chairs
John Kanellis (AU) · Raja Kandaswamy (US)
Presentations
Oral Presentation
08:00
Membrane-anchored ROS scavenger protects pancreatic islets from hypoxic injury by preserving surface thiol homeostasis
Jianmin Wu (CN)
Mini-Oral Presentation
08:10
Post-Transplant Diabetes in SPK
Lucas Garcias (AR)
08:17
🎗Challenging the marginal label: Pediatric donors in simultaneous pancreas–kidney transplantation
Belmin B J Winston Gysley (IN)
08:24
Biophysical profiling of human pancreatic organoids identifies mass density as a size-independent metric of maturation and function
Giuseppe Pettinato (US)
08:31
🎗Temporal trends in surgical morbidity and outcomes following Simultaneous Pancreas Kidney Transplantation: A 10 year single centre experience
Sai Praneeth Reddy Perugu (IN)
Rapid-Fire Presentation
08:38
Refining donor selection to expand the pancreatic islet donor pool: a retrospective cohort study
Heyang Wen (AU)
08:43
Allogeneic islet transplantation for diabetic patient post-kidney transplant diabetes in 4 cases
Yang Li (CN)
Room C4.8
Viral infections in transplantation
Viral infections in transplantation
Chairs
Monica Slavin (AU) · Bradley Gardiner (AU)
Presentations
Oral Presentation
08:00
🎗Mapping the BK polyomavirus MHC class I immunopeptidome to advance antiviral immune target discovery in kidney transplants
Tirath Dwivedi (AU)
Mini-Oral Presentation
08:10
Unsupervised Machine Learning Reveals Early BKPyV DNAemia Trajectories That Improve the Prediction of Kidney Allograft Outcomes
Gang Huang (CN)
08:17
Breakthrough CMV DNAemia in solid organ recipients on primary valganciclovir prophylaxis
Sara Belga (CA)
08:24
Cytomegalovirus DNAemia clearance with maribavir in solid organ transplant recipients with symptomatic versus asymptomatic infection: a post hoc analysis of phase 2 and 3 trials
Deepali Kumar (CA)
08:31
When CMV donor/recipient risk is not one-size-fits-all: Demographic and socioeconomic modification of CMV-associated mortality after heart transplantation
Maheen Abidi (US)
08:38
Extended antiviral prophylaxis mitigates impact of cytomegalovirus infection in seronegative lung transplant recipients
Manushika Watagodakumbura (AU)
Rapid-Fire Presentation
08:45
Early Initiation of Letermovir Prophylaxis Prevents Cytomegalovirus Infection After Liver Transplantation: A Prospective Single-Center Study
Katsunori Sakamoto (JP)
08:50
CMV specific cell mediated immunity profile in Indian kidney transplant recipients
Ramanand Sivaprasad (IN)
08:55
Utilization, Prevention, and Outcomes of Kidney Transplantation from HBsAg(+) Donors to HBsAg(-) Recipients: A Nationwide Survey of 74 Centers in Mainland China
Ying Su (CN)
Room C4.9
Novel immunosuppression
Novel immunosuppression
Presentations
Oral Presentation
08:00
Phase 2 BESTOW trial and the BESTOW EXTENSION: Evaluating the long-term safety and efficacy of tegoprubart in preventing kidney transplant rejection
Andrew B. Adams (US)
08:13
CCL22-engineered MSCs modulate immune crosstalk to shape an immunosuppressive microenvironment for graft protection
Yanan Li (CN)
Mini-Oral Presentation
08:23
Efficacy and safety of everolimus added to Tacrolimus/Mycophenolate/Prednisone in HLA-sensitized kidney transplant recipients: A randomized controled trial.
Elias David-Neto (BR)
08:30
🎗Targeted Elimination of ABO-Specific B Cells via Bispecific T-Cell-Engaging Antibody Conjugates for ABO-Incompatible Kidney Transplantation
Joon Young Jang (KR)
08:37
🎗CCR10 Defines a Potent Regulatory T Cell Subset Essential for Kidney Transplant Tolerance through Enhanced Foxp3 Lineage Stability
Siyue Chen (CN)
Rapid-Fire Presentation
08:44
Comparative effectiveness of thymoglobulin versus basiliximab for induction immunosuppression in older kidney transplant recipients: A target trial emulation
Katharine Krupp (US)
08:49
Bioequivalence of generic immunosuppressants in kidney transplants
Anders Asberg (NO)
Room C4.10
Pediatric treatments on the Horizon
Pediatric treatments on the Horizon
Presentations
08:00
Partial heart transplant in children
Edo Bedzra (US)
08:20
The micorbiome and transplantation
Maria-Luisa Alegre (US)
08:40
Regulatory cell therapy for solid organ transplantation
Fadi Issa (GB)
Room C4.11
Bridging gaps in transplantation: Equity, access, and unmet needs worldwide
Bridging gaps in transplantation: Equity, access, and unmet needs worldwide
Presentations
Mini-Oral Presentation
08:00
🎗Estimating the scale of unmet solid organ transplantation need in India: a demographic scenario analysis to 2040
Saurabh Puri (IN)
08:07
🎗Financial sustainability of Transplant Programs in low middle-income countries. A snapshot of models providing “free of cost” transplant services
Mirza Zafar (PK)
08:14
Qualitative methodologies exploring pregnancy care for First Nations women with kidney transplantation: An Aboriginal kidney care together improving outcomes now (AKction2) co-designed study
Nishanta Tangirala (AU)
08:21
“I won’t offer a kidney that I don’t think they should accept”: Nephrologists’ perspectives on patient involvement in declined deceased donor kidney transplant offers
Alison Weightman (AU)
08:28
The economics of kidney replacement therapy in Tanzania: a generalizable, state-transition model for policy-driven cost-effectiveness analyses
Alan Zambeli-Ljepović (US)
Rapid-Fire Presentation
08:35
A Time-to-Equivalent Risk (TiTER) for decision-making in deceased donor kidney transplant candidates
Jin Hyeog Lee (KR)
08:40
Sex Disparities in Transplant Waitlisting- Differences by Race, Ethnicity, and Age
Mara McAdams DeMarco (US)
08:45
Impact of the MELD-based allocation system on waitlist mortality and transplant rates in Japan: A single-center study
Ryoichi Goto (JP)
08:50
Improving organ donation in medicolegal cases a retrospective review from the UAE national center for organ donation and transplant from 2023 to 2026
Maria Gomez (AE)
TTS President's Plenary
Darling Harbour
TTS President's Plenary
TTS President's Plenary
Chairs
John J. Fung (US) · Nadey Hakim (GB)
Supported by
Presentations
Introduction to TTS President
Nadey Hakim (GB)
Presidential address
John J. Fung (US)
Presentation of the WIT Awards
Germaine Wong (AU)
Woman Leader in Transplantation Recipient
Beatriz Domínguez-Gil (ES)
WIT Unsung Hero Recipient
Thu Du (VN)
Medawar Awards
John J. Fung (US)
Introduction to Gabriel Danovitch
Jeremy Chapman (AU)
🎗2026 Medawar Recipient
Gabriel Danovitch (US)
Introduction to Maria Siemionow
John J. Fung (US)
🎗Medawar Recipient
Maria Siemionow (US)
Introduction to Haibo Wang
John J. Fung (US)
Beyond technology: Building a collaborative societal ecosystem for transplantation (Reflections from China's transplant reform)
Haibo Wang (CN)
An outside-in perspective on China
Björn Nashan (CN)
Coffee Break / Exhibits and Poster Viewing
Hall 1-2
Coffee Break
Coffee Break
No lectures assigned yet.
TTS Connect & Converse Theatre
Interview and Q&A discussions with award recipients
Interview and Q&A discussions with award recipients
Chair
Macey L. Levan (US)
Presentations
Q&A discussion with 2026 TTS - Dr. Sanjeev Kanoria Liver Transplant Award recipient
Peter J. Friend (GB)
Q&A discussion with 2026 TTS - Dr. Sanjeev Kanoria Liver Transplant Award recipient
Maria Amalia Matamoros (CR)
2026 TTS Medawar Recipient
Gabriel Danovitch (US)
2026 TTS Medawar Recipient
Maria Siemionow (US)
Abstract and Concurrent Sessions
Cockle Bay 1
Donor risk and recipient outcomes in kidney transplantation
Donor risk and recipient outcomes in kidney transplantation
Chairs
Angela Webster (AU) · John S. Gill (CA)
Presentations
Oral Presentation
11:00
The Impact of The Modified Kidney Donor Profile Index on The Non-use of Kidneys from Donors with Hepatitis C
Tarek Alhamad (US)
Mini-Oral Presentation
11:10
Does pre-donation cardiac arrest affect post-transplant outcomes in kidney transplantation: a UK NHSBT Registry Data Analysis
Zaid Al-Amiedy (GB)
11:17
1-year outcomes of kidney transplantation from donation after circulatory death using normothermic regional perfusion (NRP) – a single-center experience
Alex Zendel (US)
11:24
Long-term outcomes of kidneys from donors following medical assistance in dying
François Méthot (CA)
Rapid-Fire Presentation
11:31
Donor factors associated with poor early graft outcomes – a retrospective observational study over two decades from the ANZDATA registry
Gina Davis (AU)
11:36
Imaging-based nephron mass estimation using BSA-normalized CT renal volume predicts early remnant kidney dysfunction in living kidney donors
Manish Malik (IN)
11:41
Eplet mismatch does not predict outcomes in living related kidney transplantation as induction therapy overrides molecular risk
Kapil Vijaykumar Gothwal (IN)
11:46
Association between donor albuminuria and the risk of graft failure in living-donor kidney transplantation: A retrospective cohort study
Chengze Liang (CN)
11:51
Quality of Life After Living-Related Kidney Donation in an Indigenous High Volume Transplant Programme in Nigeria: Determinants from a WHOQOL-BREF Analysis.
Hyginus Ekwuazi (NG)
Cockle Bay 2
Immunosuppression: Experimental and clinical
Immunosuppression: Experimental and clinical
Presentations
Oral Presentation
11:00
Pre‑IND Evaluation of Orthotopic Cardiac Xenotransplantation Using Ten‑Gene‑Edited Porcine Donor Hearts with a Clinically Relevant Immunosuppressive Regimen in Non‑Human Primates
Muhammad Mohiuddin (US)
11:12
🎗Engineering tacrolimus-resistant A2-CAR Tregs for use in solid organ transplantation
Robert Wright (CA)
11:24
Donor carbon monoxide treatment alone prolongs pulmonary allograft survival and suppresses brain death-induced graft inflammation in CLAWN miniature swine
Hisashi Sahara (JP)
11:36
Lung allograft VCAM-1: a ligand for graft targeting of nanoparticles post-lung transplantation
Logan Langerude (US)
Room C3.3
Immunologic risk, donor factors and predictive modelling of kidney transplant outcomes
Immunologic risk, donor factors and predictive modelling of kidney transplant outcomes
Chairs
Alessandra Orsillo (AU) · Kate Wyburn (AU)
Presentations
Mini-Oral Presentation
11:00
Three-year incidence and phenotype of de novo donor-specific antibodies and complement-binding subsets after kidney transplantation: results from the DOSAKOM phase IV cohort
Jun Bae Bang (KR)
11:07
Homozygosity at HLA-A, especially the A24 antigen, is an independent risk factor for higher PRA post-transplant and reduced opportunities of subsequent transplant
Gerard Chu (AU)
11:14
Impact of donor hypertension on kidney transplant outcomes - An analysis of the Collaborative Transplant Study (CTS)
Christian Unterrainer (DE)
11:21
Temporal decay in the performance of Cox proportional hazards models for deceased-donor kidney graft survival
Aniket Sinha (AU)
Rapid-Fire Presentation
11:28
Development of a multidimensional machine learning model integrating clinical, perfusion, donor scoring and pathology data for predicting delayed graft function in deceased donor kidney transplantation
Guozhen Chen (CN)
11:33
Serum induced trained immunity responses are associated with clinical outcomes after pediatric kidney transplantation
Longshan Liu (CN)
11:38
Gene Spark: Genetic Survey of Paediatric Kidney Transplant Patients
Ananya Deshpande (AU)
11:43
Longitudinal Graft Function Trajectories in Crossmatch-Positive Living Kidney Transplantation
Toshihito Hirai (JP)
11:48
Machine learning prediction of 30-day bleeding complications in desensitized kidney transplant recipients
Ahram Han (KR)
11:53
A systematic method to evaluate kidney allocation algorithms in Australia
Owen Ng (AU)
Room C3.4-C3.5
Immunoregulation: Cell signalling 1
Immunoregulation: Cell signalling 1
Chairs
Michaela Lucas (AU) · Shane Grey (AU)
Presentations
Oral Presentation
Targeting VDR-sirt5-PHB2-mediated mitophagy to reverse vascular endMT and prevent chronic renal allograft dysfunction
Qinghuan Shen (CN)
G-MDSC derived LETS1 promotes mesenchymal stem cell differentiation into myofibroblasts via targeting TGF Beta Receptor I in renal fibrosis
Xinhao Niu (CN)
A mechanistic model to investigate Non-HLA Mismatches in LIMS1-GCC2.
Madhav Menon (US)
Targeting Innate Allorecognition Via CD47-Sirpa Prolongs Cardiac Allograft Survival In Presensitized Recipients
Martin Oberbarnscheidt (US)
The transcription factor Bhlhe40 promotes alloreactive CD8+ T cell differentiation from TCF-1+ effector progenitors in Graft-vs-Host Disease
Kate Gartlan (AU)
Room C3.6
Multi-omics and immune profiling in transplantation: Kidney-focused advances with cross-organ insights
Multi-omics and immune profiling in transplantation: Kidney-focused advances with cross-organ insights
Chairs
Ruth Sapir-Pichhadze (CA) · Jen Li (AU)
Presentations
Oral Presentation
11:00
Deep Characterization of the Kidney Transplant Immune Microenvironment via Multimodal Deep Learning and Single-Cell Spatial Transcriptomics
Jiaheng Wu (CN)
11:10
Distinguishing Pathogenic Alloimmunity from Immunological Noise in DSA-Negative Kidney Rejection: A Multimodal Framework Validated in GSTT1-Null Recipients
Xiantian Pan (CN)
Mini-Oral Presentation
11:20
Spatial multi-omics dissection of tertiary lymphoid structure maturation and composition predicts post-transplant outcomes and pre-operative immunotherapy response in hepatocellular carcinoma
Zhikai Jiang (CN)
11:27
A systematic review of reported use of genetic testing in kidney transplantation
Sadia Jahan (AU)
11:34
Integration of a pre-transplant 15-protein serum proteomic signature predicts recurrence after liver transplantation for HCC: A multicenter KOTRY registry study
Suk Kyun Hong (KR)
11:41
Potential Value of Targeting the TIM-4/PS Signaling Pathway in Promoting Immune Tolerance in Kidney Transplantation
Qiang Fu (CN)
11:48
Genome-wide investigation of variants associated with kidney allograft survival
Angelita Liang (AU)
Room C4.1
Transplant outcomes, bridging strategies, and global advances in liver transplantation
Transplant outcomes, bridging strategies, and global advances in liver transplantation
Chairs
Simone I. Strasser (AU) · Pranjal Modi (IN)
Presentations
Mini-Oral Presentation
11:00
HLA-DQ molecular mismatch-derived risk score predicts acute rejection and development of de novo donor-specific antibodies in pediatric liver transplantation
Agostina Arrigone (AR)
11:07
Liver transplantation after neoadjuvant TACE in HCC: impact of cone-beam CT on bridging and downstaging strategies assessed by the Metroticket 2.0 model
Sergey Astapovich (RU)
Rapid-Fire Presentation
11:14
Post-Transplant Lymphoproliferative Disorder in Paediatric Liver Transplantation: A National Centre Experience from New Zealand
Yae Jhee Lee (NZ)
11:19
Outcomes of liver transplantation for metabolic dysfunction–associated steatotic liver disease in the United States
Reza Saidi (US)
11:24
Perioperative glucose alterations and liver transplantation outcomes: A Mongolian cohort study
Sergelen Orgoi (MN)
11:29
The role of international collaboration in developing transplant programs: A success story from TTS-ILTS paired transplant centers program from the Paired Program
Sergelen Orgoi (MN)
11:34
Establishing a protocol for liver transplantation in unresectable colorectal liver metastases: Preliminary results of an Australian clinical trial
Arsalan Bakhtiar (AU)
11:39
Optimal frequency of high-flow hemodiafiltration as a bridging therapy to liver transplantation in patients with acute liver failure in Japan.
Kosei Nakamura (JP)
11:44
Efficacy of transarterial radioembolization versus transarterial chemoembolization as bridging therapy to liver transplantation for patients with hepatocellular carcinoma
Arpit Amin (US)
11:49
Liver transplantation outcomes in patients with secondary biliary cirrhosis following bile duct injury
Eduardo Massabki (BR)
Room C4.2
Vascularized composite allotransplantation: Expanding frontiers in function, immunity, and clinical translation
Vascularized composite allotransplantation: Expanding frontiers in function, immunity, and clinical translation
Chairs
Patrik Lassus (FI) · Peter J. Friend (GB)
Presentations
Mini-Oral Presentation
11:00
Defining long-term functional recovery in face transplantation
Bruce Gelb (US)
11:07
3-year longitudinal outcomes after the world’s first human whole eye transplant
Bruce Gelb (US)
11:14
Human limb preservation using oxygenated machine perfusion with hemoglobin-based oxygen carriers modulates hypoxia and immune injury pathways
Varun Kopparthy (US)
11:21
Vascular Composite Allograft Transplantation – A Single Center Experience From India
Shruti Tapiawala (IN)
11:28
Emerging divides in attitudes towards uterus transplantation among health professionals in Australia and New Zealand
Hayley Mallinder (AU)
11:35
Psychological and emotional profiles of Australian uterine transplant potential recipients: a comparison with international trials
Tamika Baker (AU)
11:42
A decade of structural inequity in U.S. vascularized composite allotransplantation - A National OPTN Registry Analysis (1998–2024)
Girish Mour (US)
11:49
NASEM-Guided CONSORT Consensus Recommendations and Standards for Face and Hand Vascularized Composite Allotransplantation: Establishing a Multicenter Clinical Trial Framework
Vijay Gorantla (US)
Room C4.4
The journey to clinical xenotransplantation
The journey to clinical xenotransplantation
Chairs
Leonardo Riella (US) · Evelyn Salvaris (AU)
Presentations
Presenting the XenoPrize
Wayne J. Hawthorne (AU)
2025 Carl-Gustav Groth Xeno Prize for the paper on "Desensitization with Proteasome Inhibition and Costimulation Blockade Modulates the Xenoreactive Humoral Response in Nonhuman Primate Xenotransplantation"
Brendan P. Lovasik (US)
11:05
Development of the gene edited pigs to get us to the clinic
Peter Cowan (AU)
11:25
Avoiding dysregulation of the complement and coagulation-anticoagulation systems?
Jo Tector (US)
11:45
The road to regulatory approval for clinical transplantation
Muhammad Mohiuddin (US)
Room C4.5
Expanding living donor liver transplantation: Emerging evidence and clinical advances
Expanding living donor liver transplantation: Emerging evidence and clinical advances
Chairs
Kwang Woong Lee (KR) · Dong Jin Joo (KR)
Presentations
Oral Presentation
11:00
Liver transplantation from donation after circulatory death in the United States: Elderly donors emerge as a critical resource
Allan Massie (US)
11:10
How Can We Ensure Donor Safety with Less than 30% of Residual Volume?
Joodong Kim (KR)
Mini-Oral Presentation
11:20
Quality of Life After Robotic Living Donor Hepatectomy: A One-Year Prospective Analysis of Donor and Recipient Determinants
Dieter Broering (SA)
11:27
A comparison of total intravenous and volatile anesthesia in living donor hepatectomy: A global prospective cohort study from the International Living Donor Liver Transplant Registry
Marina Berenguer (ES)
11:34
Accuracy of MRI-PDFF and FibroScan CAP for Assessing Steatosis in Living Liver Donors: A Multivariate Analysis with Weight Stability Compensation
Eunjin Lee (KR)
Rapid-Fire Presentation
11:41
Laparoscopic Donor Left vs. Right Hepatectomy: A Propensity Score-Matched Analysis of Donor Safety and Outcomes
Eunjin Lee (KR)
11:46
Urgent liver transplantation for acute-on-chronic liver failure in national data: Impact of dynamic MELD change and donor type on survival
Jongman Kim (KR)
11:51
Family perspectives on deceased organ donation: a meta-synthesis of qualitative studies on post-donation experiences and attitudes
Qingqing Zhou (CN)
Room C4.6
Lung transplantation outcomes and allograft dysfunction: From mechanisms to clinical prevention strategies
Lung transplantation outcomes and allograft dysfunction: From mechanisms to clinical prevention strategies
Chairs
Gregory I. Snell (AU) · Jyotika Prasad (AU)
Presentations
Oral Presentation
11:00
Clinical, histological and tissue proteomic features of decline after idiopathic acute lung allograft dysfunction
Pamela Karas (AU)
Mini-Oral Presentation
11:10
Longitudinal immunophenotyping identifies early postoperative CD8-positive PD-1-positive T cells as an independent predictor of 1-year mortality after lung transplantation
Tianyi Yang (CN)
11:17
Predicting acute kidney injury following lung transplantation: development and internal validation of perioperative prediction models
Shogo Trevena (AU)
11:24
Family Experiences and Ethical Acceptability of Lung uDCD Authorization in an Opt-In System
Jingzhi Xu (US)
Rapid-Fire Presentation
11:31
Donor Lung Microbiome and Metabolic Signatures Predict Primary Graft Dysfunction After Lung Transplantation
Guodong Wu (CN)
11:36
Randomized controlled trial comparing immediate versus extended-release tacrolimus in lung transplant recipients: the REVOLUTION trial
Juul Daamen (NL)
11:41
Excellent Long-Term Outcomes in Paediatric Lung Transplantation Within a Centralised, Co-located Adult Program
Miranda Paraskeva (AU)
11:46
Lung Allograft Injury Improves After Gastroesophageal Reflux Surgery According To Donor-derived Cell-free DNA
Cesar Escrig (CH)
Room C4.7
Psychosocial, communication and educational aspects of donation and transplantation
Psychosocial, communication and educational aspects of donation and transplantation
Presentations
Oral Presentation
11:00
🎗You don’t know what you don’t know: Developing video-based educational resources for prospective kidney transplant recipients
Darren Manden (NZ)
11:10
Exploring lived experiences of kidney graft loss through narrative podcasting
Anita Slominska (CA)
Mini-Oral Presentation
11:20
Barriers to effective communication about kidney graft failure: findings to guide intervention development
Anita Slominska (CA)
11:27
'Recognizing how much the kidney transplant would hold me back': A qualitative explorative study and a digital storytelling project with young adult kidney transplant recipients
Chloe Wong-Mersereau (CA)
11:34
Posttraumatic Distress Symptoms in Patients on Mechanical Circulatory Support
Christiane Kugler (DE)
Rapid-Fire Presentation
11:41
Psychological resilience and post-kidney transplant psychosocial outcomes
Kathleen Gaudio (CA)
11:46
The role of community in the well-being of living kidney donors
Kathleen Gaudio (CA)
Room C4.8
Global Transplantation: The GODT Report Analyzes Activities Around the World
Global Transplantation: The GODT Report Analyzes Activities Around the World
Presentations
11:00
Global observatory on donation and transplantation (GODT)
Beatriz Domínguez-Gil (ES)
11:15
Global donation and transplantation activities. An assessment of 2024 GODT data
Friederike Martin (DE)
11:40
Panelist
John J. Fung (US)
Panelists
Nadey Hakim (GB)
Panelist
David Thomson (ZA)
Panelist
Dimitri A. Raptis (SA)
Room C4.9
Optimizing and utilizing old organ donors
Optimizing and utilizing old organ donors
Chairs
Helen Opdam (AU) · Jeffrey Orlowski (US)
Presentations
11:00
Setting the stage: Older organs - clinical need, ethical and economic considerations
Krista Lentine (US)
11:20
Objective quality criteria of old organs
Varvara Kirchner (US)
11:40
Old organs and ex vivo treatment
Jasper Iske (DE)
Room C4.10
Pediatric liver
Pediatric liver
Chairs
Helen Evans (NZ) · Michael Stormon (AU)
Presentations
Oral Presentation
11:00
HOPE improves outcomes of ex situ split liver grafts in pediatric liver transplantation
Javier Serradilla (ES)
11:10
Incidence of cognitive dysfunction in children after liver transplantation: a systematic review and meta-analysis
Qingqing Zhou (CN)
11:20
Liver transplantation for gestational alloimmune liver disease outcomes analysis from retrospective cohort and national case series
Shreya Tamma (US)
Mini-Oral Presentation
11:30
Infant versus paediatric liver transplantation: technical and survival outcomes in a single-centre cohort study
Yang Yang Lee (SG)
11:37
The Survival Benefit of Pediatric Liver Transplantation
Ali Abbasi (US)
11:44
The impact of early mortality on the survival benefit of pediatric liver transplantation for primary liver malignancy
Ali Abbasi (US)
Room C4.11
Therapeutic organ perfusion: From organ rescue to advanced clinical applications
Therapeutic organ perfusion: From organ rescue to advanced clinical applications
Chairs
Dale Gardiner (GB) · Sarah Scheuer (AU)
Presentations
Oral Presentation
11:00
First-in-Human Application of Extracorporeal Diseased Liver Perfusion Support (EDLPS) for Liver Failure
Xiaoshun He (CN)
11:10
Development of the first pediatric DCD normothermic machine perfusion program: meeting the unmet need in pediatric liver transplantation
Chun-Sing (Kevin) Huang (US)
11:20
The First 500 Kidneys Rescued Using Subnormothermic Acellular Perfusion (SNAP) at a Centralized Facility
Giselle Guerra (US)
Mini-Oral Presentation
11:30
Subnormothermic machine perfusion for small intestinal ischemia reperfusion injury suppression and functional maintenance
Satoshi Muto (JP)
11:37
Impact of Normothermic Perfusion Strategies on Early Liver Transplant Outcomes: A Comparison of On-Site versus Back-to-Base Strategies
Santosh Nagaraju (US)
Rapid-Fire Presentation
11:44
Targeting the TCF4-COL4A-CD44 axis ameliorates neutrophil-mediated inflammation during Ex Vivo liver normothermic machine perfusion
Meiting Qin (CN)
11:49
Normothermic machine perfusion in high-acuity liver transplants with increased operative complexity: a comprehensive single-center experience
Reghan Conrey (US)
Lunch Break / Industry Symposia / Lunch with Experts & Mentors
Parkside 1&2
Astellas Corporate Lunch Symposium on Strengthening the foundation: How consistent management drives durable graft health
Astellas Corporate Lunch Symposium on Strengthening the foundation: How consistent management drives durable graft health
Chair
Teun van Gelder (NL)
Organized by
Presentations
12:15
Opening: Examining the foundation of graft protection
Teun van Gelder (NL)
12:20
Case 1: Formulation change in a stable recipient - Is stability truly preserved?
Dirk Kuypers (BE)
12:35
Data spotlight: What do real-world evidence and guidelines tell us about formulation consistency?
Dirk Kuypers (BE)
12:45
Case 2: Increased intra-patient variability - When do you intervene?
Teun van Gelder (NL)
13:00
Discussion: Practical strategies to optimize consistency in daily practice
Teun van Gelder (NL)
13:10
Closing summary: Strengthening the foundation through consistent immunosuppression
Teun van Gelder (NL)
Pyrmont Theatre Foyer
Lunch and Learn Roundtable
Lunch and Learn Roundtable
Presentations
Living donor kidney transplantation & paired exchange
Jigar Shrimali (IN)
BK Guidelines
Camille N. Kotton (US)
Transplant immunology & kidney injury
Natasha Rogers (AU)
Nursing Leadership in Transplant and Donation Systems
Anne Floden (SE)
Roundtable Mentor
Peter G. Stock (US)
DCD thoracic transplant
Gregory I. Snell (AU)
"Organ Donation: From Death to Life". How to improve education about organ donation
David Thomson (ZA)
Organ preservation, rejuvenation, and perfusion techniques
Stefan Tullius (US)
AMR in kidney transplant recipients
William Mulley (AU)
What strategies can effectively prevent unethical practices in donation and transplantation?
Maria Amalia Matamoros (CR)
TTS Connect & Converse Theatre
Meet the incoming TTS Presidents
Meet the incoming TTS Presidents
Chair
Sarah Francom (US)
Presentations
Meet the incoming TTS President
Nadey Hakim (GB)
Meet the TTS President-Elect (2026-2028)
Gabriel E. Gondolesi (US)
SOTA, Thematic and Concurrent Sessions
Cockle Bay 2
Targeting immune cell metabolism to control alloimmunity
Targeting immune cell metabolism to control alloimmunity
Presentations
13:30
How T cell metabolism regulates function and survival
Carl Atkinson (US)
13:50
Treg metabolism and the impact of metabolites on their function and disease progression
Ling Lyu (CN)
14:10
Targeting Innate Immunometabolism in Organ Transplantation
Yohana Toner (NL)
14:30
T cell landscapes following hematopoietic stem cell transplantation
Antiopi Varelias (AU)
Room C3.3
Redefining Surgical Excellence: Metrics, Equity, and Global Perspectives
Redefining Surgical Excellence: Metrics, Equity, and Global Perspectives
Chairs
Animesh Singla (AU) · Peter G. Stock (US)
Presentations
13:30
Driving quality improvement through global surgical registries
Dimitri A. Raptis (SA)
13:50
Novel outcome metrics in surgery: Beyond survival to value-based excellence
Yolanda Becker (US)
14:10
Ensuring diversity in the transplant surgery workforce
Kendra Conzen (US)
14:30
Beyond steatosis: The multisystem metabolic nature of fatty liver disease and its impact on surgical outcomes
Nazia Selzner (CA)
Room C3.4-C3.5
Deceased Donation Research: Findings and Future Directions
Deceased Donation Research: Findings and Future Directions
Chair
Dominique Martin (AU)
Presentations
13:30
Donor intervention studies – ethical and practical challenges
Dale Gardiner (GB)
13:40
Deceased donor physiological management research
Gary F. Marklin (US)
13:50
Thoracic ex-situ machine perfusion research
Sarah Scheuer (AU)
14:00
Biobanks for research
Claire Gordon (AU)
14:10
Panel Discussion
Discussion Period (AU)
Room C3.6
Pluripotent stem cells and regenerative medicine: the future of transplantation?
Pluripotent stem cells and regenerative medicine: the future of transplantation?
Chair
Edward Geissler (DE)
Presentations
13:30
Developing an engineered heart tissue patch for heart failure.
Enzo Porrello (AU)
13:50
Pluripotent stem cells: Where are we in building new lungs?
Rhiannon Werder (AU)
14:10
Tissue engineering and regenerative medicine: Perspectives on recent developments and directions
Anthony Weiss (AU)
14:30
Stem cell derived islets under abdominal anterior rectus sheath in a type 1 diabetes patient
Shusen Wang (CN)
Room C4.1
Biology and beyond: Multiple dimensions of transplantation
Biology and beyond: Multiple dimensions of transplantation
Presentations
13:30
Addressing gender disparity in access to pediatric kidney transplantation in India
Kinnari Vala (IN)
13:50
Social and cultural conflicts in uterine transplantation
Limor Meoded Danon (IL)
14:10
Impact of sex on cardiovascular outcomes after pediatric kidney transplantation
Rizky Indrameikha Sugianto (DE)
14:30
Intersection of sex/gender, and cancer after transplantation
Brenda Maria Rosales (AU)
Room C4.2
Life after transplant: Supporting movement, confidence, and long-term recovery across all levels of ability (WTGF)
Life after transplant: Supporting movement, confidence, and long-term recovery across all levels of ability (WTGF)
Chairs
Chris Thomas (AU) · Kate Wyburn (AU)
Presentations
13:30
The long-term transplant journey: What patients experience after discharge
Liz Schick (CH)
13:45
Movement when endurance is limited: Finding confidence through everyday activity
Geoff Jessup (AU)
14:00
From recovery to endurance sport: The transformative role of movement
Kate Clark (AU)
14:15
Clinical perspective: Encouraging safe physical activity after transplant
Geoffrey McCaughan (AU)
14:30
Panel discussion: Supporting all patients to move
Discussion Period (AU)
Room C4.4
Transplanting Against the Antibody Odds
Transplanting Against the Antibody Odds
Chairs
Ankit Sharma (AU) · Anne Halpin (CA)
Presentations
13:30
Overview of new HLA tools for measuring antibodies and rapid high resolution sequencing
Sandra Tafulo (PT)
13:50
Crossing DSA in lung transplant: Is necessity the mother of invention?
Kieran Halloran (CA)
14:10
Immune memory responses: Unmasking the hidden antibody potential
Gonca E. Karahan (NL)
14:30
Organ allocation strategies for HLA compatibility
Philip Andrew Clayton (AU)
Room C4.5
Emerging infectious diseases in transplant ID
Emerging infectious diseases in transplant ID
Chairs
Olivia Smibert (AU) · Tina Marinelli (AU)
Sponsored by
Presentations
13:30
Climate change and the changing epidemiology of transplant infections
Wanessa T. Clemente (BR)
13:50
On the move: Migration and the globalization of emerging pathogens
Monica Slavin (AU)
14:10
New outbreaks of old diseases: Measles and other re-emerging threats in transplantation
Cameron R. Wolfe (US)
14:30
Disease X and vaccine
Deepali Kumar (CA)
Room C4.6
Honouring voices, changing systems: Indigenous leadership in transplant equity
Honouring voices, changing systems: Indigenous leadership in transplant equity
Presentations
13:30
Indigenous peoples and organ donation and transplantation in Canada: Improving access to care
Aviva Goldberg (CA)
13:50
Ka whawhai tonu, ka haere ake: Fighting to advance transplant equity in Aotearoa New Zealand
Curtis Walker (NZ)
14:10
Wangkanthi purdita purruna naalitya - Talking kidney health for you Mob
Kelli Owen (AU)
Co-Presenting: Wangkanthi Purdita Purruna Naalitya - Talking Kidney Health for you Mob
Stephen McDonald (AU)
14:30
Panel Discussion and Q&A
Discussion Period (AU)
Room C4.7
Artificial intelligence (AI) in Transplant Education
Artificial intelligence (AI) in Transplant Education
Presentations
13:30
From concept to classroom: How to start using AI in transplant education?
Susu Zughaier (QA)
13:50
Mixed reality technology in organ transplantation
Alfred Kow (SG)
14:10
AI in Transplantation: AI capabilities, applications and responsible use
Bill Simpson-Young (AU)
14:30
Panel Discussion
Discussion Period (AU)
Panelist
Ala Ali (IQ)
Room C4.8
Global collaboration in organ transplantation: Advancing ethical access, innovation, and sustainability
Global collaboration in organ transplantation: Advancing ethical access, innovation, and sustainability
Chairs
Rajdeep Das (US) · Marcelo Cantarovich (CA)
Presentations
13:30
Global organ sharing & research collaborations
Axel Rahmel (DE)
13:50
Economics of transplantation
Vasanthi Ramesh (IN)
14:10
Capacity building in low-resource settings
Medhat Askar (US)
14:30
Ethical, cultural & patient-centered considerations
Jeremy Chapman (AU)
Room C4.9
Transplant Oncology: Peering Over the Horizon
Transplant Oncology: Peering Over the Horizon
Chairs
Kwang Woong Lee (KR) · Mohamed Rela (IN)
Presentations
13:30
Liver transplantation for unresectable hilar cholangiocarcinoma: Who truly benefits?
Julie K. Heimbach (US)
13:47
Neuroendocrine tumours and liver transplantation: Time to move beyond traditional boundaries?
Takashi Ito (JP)
14:04
Intrahepatic cholangiocarcinoma and liver transplantation: Pushing the limits of what’s surgically and biologically possible
Sudha Kodali (US)
14:21
Liver transplantation for hepatoblastoma: Does biology drive the decision to transplant?
Mohamed Rela (IN)
14:38
Liver transplantation for non-hepatoblastoma paediatric tumours: LT as a curative tool?
Seisuke Sakamoto (JP)
Room C4.10
ISOT: Redefining organ transplantation in resource-limited settings: Access, affordability, and global leadership from India - Part 1
ISOT: Redefining organ transplantation in resource-limited settings: Access, affordability, and global leadership from India - Part 1
Room C4.11
Obesity Management in Transplantation: Current Evidence and Practical Approaches
Obesity Management in Transplantation: Current Evidence and Practical Approaches
Chairs
Dorry Segev (US) · Marina Berenguer (ES)
Presentations
13:30
Latest evidence on GLP-1s in transplantation
Babak Orandi (US)
13:50
Managing obesity without GLP-1s: Alternative strategies
Amanda Velazquez (US)
14:10
Bariatric surgery in transplantation: Opportunities and challenges
Shashank R. Joshi (IN)
14:30
Facilitating weight loss in individuals with frailty and sarcopenia
Astrid Ruiz-Margáin (MX)
Coffee Break / Exhibits and Poster Viewing
Hall 1-2
Coffee Break
Coffee Break
No lectures assigned yet.
TTS Connect & Converse Theatre
DEI-WIT activities and award recipients
DEI-WIT activities and award recipients
TSANZ President Session / Afternoon Abstract and Concurrent Sessions
Cockle Bay 1
TSANZ President's Prize Awards
TSANZ President's Prize Awards
Presentations
15:30
TSANZ President's prize welcome
Nicole Isbel (AU)
15:40
Validation of a novel non-invasive method based on evaluating urinary exfoliated proximal tubule kidney cell multispectral autofluorescence to differentiate between causes of kidney transplant complications
Henry H L Wu (AU)
15:55
Developing a prediction model for the time from withdrawal of cardiorespiratory support to death in controlled donation after circulatory determination of death donors
Ryan Gately (AU)
16:10
Immune invisible kidney allografts: eliminating MHC II expression with cytosine base editing to prevent antibody-mediated kidney transplant rejection
Ailish Barry (AU)
16:25
Impact of Repeat HLA Mismatches on Graft Outcomes in Kidney Transplantation in Australia
Henry Guo (AU)
16:40
🎗A single-cell imaging atlas of the peripheral immune system in kidney transplant recipients
Griffith Perkins (AU)
16:55
Fatherhood and Kidney Replacement Therapy: Analysis of linked ANZDATA Registry and perinatal data
Su Jen Chua (AU)
17:10
Peripheral T cell transcriptomic profile is altered in non-human primate kidney transplant recipients treated with ECDI-fixed donor B cell infusions
Matthew Tunbridge (AU)
17:25
Who gets a kidney transplant? International differences in kidney transplant waitlisting, transplantation and mortality in the US, UK and Australia
Lachlan McMichael (AU)
17:40
Closing remarks
Nicole Isbel (AU)
Cockle Bay 2
Organ preservation 2
Organ preservation 2
Chairs
Henry Pleass (AU) · Carlo Pulitano (AU)
Presentations
Oral Presentation
15:30
Metabolic reprogramming by modulation of histone lactylation improves liver graft preservation and function
Xiao Tang (CN)
15:40
🎗Towards next-generation organ preservation - molecular insights from long-term normothermic machine perfusion of human livers for up to 7 weeks
Anita Niu (AU)
15:50
Histone acetylation improves liver graft function via ADCY3-cAMP-mediated metabolic reprogramming
Zhoucheng Wang (CN)
16:00
The First Demonstration of Kidney Allo- and Autotransplantation After 72 Hours of Simple, Cryoprotectant-Free Subzero Preservation, with Pilot Extension to 96–120 Hours
Timothy Lane Pruett (US)
Mini-Oral Presentation
16:10
Hypothermic Oxygenated or Normothermic Kidney Perfusion – Which Perfusion Technique Protects Mitochondria Best?
Keyue Sun (US)
16:17
Inhibiting ferroptosis alleviates cold-induced injury in porcine lung tissue slices
Fernanda Yamamoto Ricardo da Silva (CA)
Room C3.3
Biomarkers, pharmacokinetics and kidney allograft outcomes
Biomarkers, pharmacokinetics and kidney allograft outcomes
Chairs
Toby Coates (AU) · John S. Gill (CA)
Presentations
Oral Presentation
15:30
Autonomous AI pathology and spatial transcriptomics reveal inflammatory niches driving i-IFTA in kidney allografts
Harry Robertson (AU)
15:40
Combined genomic transplant and pharmacogenomic risk assessment for pediatric renal patients using Oxford Nanopore Adaptive Sampling
Karen Sherwood (CA)
Mini-Oral Presentation
15:50
A Multicenter Randomized Controlled Trial Of Urine CXCL10 Monitoring Post-Kidney Transplant
Julie Ho (CA)
15:57
Consistently Low Donor-derived Cell-Free DNA Identifies Allograft Stability In Kidney Transplant Recipients
Hossein (Hoss) Tabriziani (US)
16:04
Biopsy-proven recurrent IgA nephropathy after kidney transplantation in a multi-ethnic Southeast Asian cohort
Hersharan Sran (SG)
Oral Presentation
16:11
Evaluating urinary volatile organic compounds as a novel metabolomic biomarker to differentiate between acute tubular necrosis and acute graft rejection following kidney transplantation
Henry H L Wu (AU)
Room C3.4-C3.5
Immunoregulation: Cell signalling 2
Immunoregulation: Cell signalling 2
Chairs
Kate Gartlan (AU) · Xinhao Niu (CN)
Presentations
Oral Presentation
15:30
Investigation of immune responses to SLA-derived antigens presented on HLA class II
Ken Kawada (JP)
Mini-Oral Presentation
15:40
Spatial Transcriptome Analysis Identifies Endothelial HLA-F as a Prognostic Marker in Kidney Antibody-Mediated Rejection
Toshihito Hirai (JP)
15:47
RGS19 links autophagy dysfunction to CD8+ T cell-driven renal fibrosis via mTOR signaling
Xinhao Niu (CN)
15:54
Reversing TCMR through inhibition of innate immune allorecognition
Geoffrey Camirand (US)
16:01
The “inflamed self” – perturbations of the murine immunopeptidome during ischaemia-reperfusion injury and transplantation
Alexandra Hill (AU)
16:08
PHLDA1 as a Key Regulator in Renal Ischemia-Reperfusion Injury: Implications for Fatty Acid Metabolism and Ferroptosis
Zejiaxin Niu (CN)
16:15
Role of CXCL10 in Mediating T-Cell Infiltration and Phenotypic Remodeling in Renal Ischemia-Reperfusion Injury in Mice
Tian Wei (CN)
Room C3.6
Precision immunosuppression and therapeutic optimization in transplantation: Kidney-centered advances across solid organ care
Precision immunosuppression and therapeutic optimization in transplantation: Kidney-centered advances across solid organ care
Presentations
Oral Presentation
15:30
Edge-AI-enabled Aptamer Impedance Biosensor for Real-time Point-of-care Tacrolimus Therapeutic Drug Monitoring
Juhan Lee (KR)
15:40
A clinical study on the reduction of donor lymphocyte chimerism rate in recipient tissues after liver transplantation by extracorporeal perfusion of anti-thymocyte globulin via portal vein
Jinzhen Cai (CN)
Mini-Oral Presentation
15:50
10-year analysis of low-Tacrolimus/Everolimus versus regular triple therapy for elderly recipients. The nEVERold trial
Elias David-Neto (BR)
15:57
Proton-pump inhibitors: an opportunity for deprescribing in the solid organ transplant population
Anna Posthumus (NL)
16:04
Building model-informed precision dosing platforms for tacrolimus in lung, heart and bone marrow transplantation
Dirk Kuypers (BE)
Rapid-Fire Presentation
16:11
An algorithm-driven predictive strategy for personalized tacrolimus dosing in kidney transplant recipients
Guodong Chen (CN)
16:16
Balanced Electrolyte Solutions in Kidney Transplantation: CARI Guidelines Evidence-Based Recommendations for Improved Outcomes:
David Tunnicliffe (AU)
16:21
Efficacy and safety of low dose trimethoprim-sulfamethoxazole for pneumocystis jirovecii pneumonia in kidney transplant recipients: a retrospective cohort study
Xuqin Jiang (CN)
Room C4.1
Overcoming immune barriers in xenotransplantation: From innate recognition to gene-edited graft compatibility
Overcoming immune barriers in xenotransplantation: From innate recognition to gene-edited graft compatibility
Chairs
Richard N. Pierson (US) · Peter Cowan (AU)
Presentations
Oral Presentation
15:30
Loss of Neu5Gc in donor erythrocytes unlocks species-specific innate checkpoints governing macrophage recognition in xenotransplantation
Wang Yi (CN)
15:40
Normothermic Machine Perfusion of Human Kidneys Using Triple-Knockout Pig Red Blood Cells
Shuangjin Yu (CN)
15:50
Human Thrombomodulin Improves Early Coagulopathy, but Innate Immune–Driven Injury Limits Survival in Pig-to-NHP Liver Xenotransplantation
Zhongqiang Zhang (CN)
16:00
First Large-Cohort Study Profiling the Baseline Immunological Status for Xenotransplantation in Liver Transplant Candidates: Implications for Safe Bridging from Gene-Edited Pigs
Liaoran Wang (CN)
16:10
Antibody responses against swine leukocyte antigens contribute to early rejection after pig-to-monkey kidney xenotransplantation
Hao Feng (CN)
16:20
Preformed and De Novo Xenoreactive IgM Antibodies Contribute to Early Xenograft Loss in Pig-to-Monkey Kidney Xenotransplantation
Man Zhang (CN)
Mini-Oral Presentation
16:30
Sequential Allotransplantation After Failure of Pig-to-Rhesus monkey Kidney Xenotransplantation: A Case Report
Man Zhang (CN)
16:37
Flow cytometry immune profiling provides early detection of rejection of islet xenotransplants
Thanh Le (AU)
16:44
HLA E CD94 NKG2A pathway confers superior NK cell resistance compared to extensive multitransgenic modifications in porcine endothelial cells
Jonathan Schulz (DE)
16:51
Endothelial PlexinB2 suppresses human neutrophil activation in a humanized xenotransplantation model
Shuji Miyagawa (JP)
Room C4.4
Imaging and biomarkers to assess kidney allograft dysfunction
Imaging and biomarkers to assess kidney allograft dysfunction
Chairs
Samuel Neeling (AU) · Terence Kee (SG)
Presentations
Oral Presentation
15:30
Integrated immune profiling distinguishes polyomavirus nephropathy from rejection phenotypes in kidney allografts
Binnaz Handan Ozdemir (TR)
Mini-Oral Presentation
15:40
Donor-derived Cell-free DNA As A Prognostic Biomarker In Biopsy-negative Kidney-transplant Recipients
Hossein (Hoss) Tabriziani (US)
15:47
Ultrasound assessment of the effect of patient position and body shape on peri-operative renal transplant cortical resistive indices and perfusion
Charles Fisher (AU)
15:54
Real world experience of using the molecular microscope diagnostic system MMDx in the management of allograft dysfunction in a multiethnic asian kidney transplant recipient population
Terence Kee (SG)
Rapid-Fire Presentation
16:01
The influence of ultrasound guidance quality on kidney transplant biopsy outcomes: A systematic review and meta-analysis
David Su (AU)
16:06
Genetic association in patients with chronic kidney disease of undetermined etiology: An observational study
Tarun Kumar (IN)
16:11
Donor-derived cell-free DNA during delayed graft function: Insights from the KOAR registry
Giselle Guerra (US)
16:16
Contrast-Enhanced Ultrasound in differentiating Acute Rejection from Acute Tubular Necrosis based on biopsy results in Renal Allograft Dysfunction: a Prospective Study
Sai Aishwarya Valluri (IN)
Room C4.5
Optimization strategies in living donor liver transplantation
Optimization strategies in living donor liver transplantation
Presentations
Mini-Oral Presentation
15:30
The 2023-2025 Global Report Of The International Living Donor Liver Transplant Registry
Dimitri A. Raptis (SA)
15:37
Graft-to-Recipient Weight Ratio, Graft Inflow Modulation, and Small-for-Size Syndrome: A Multicenter Prospective Study from the International Living Donor Liver Transplant Registry (LDLTregistry.org)
Dimitri A. Raptis (SA)
15:44
Risk-Benefit Benchmarking in Liver Transplantation for Hepatocellular Carcinoma: a cohort study based on the CLTR and UNOS database
Fengqiang Gao (CN)
15:51
Impact of Preoperative Weight Reduction on Donor and Recipient Outcomes in Living Liver Transplantation
Jaehyun Kwon (KR)
15:58
Outcomes of highly urgent ABO-incompatible living donor liver transplantation in national databases
Jae-Won Joh (KR)
Rapid-Fire Presentation
16:05
Robotic donor hepatectomy is associated with superior long-term outcomes compared to laparoscopic or open: A single-center prospective registry study of 2,102 cases
Saleh Alabbad (SA)
16:10
Infrared Thermal Imaging Enables Real-Time Mapping of Perfusion Heterogeneity and Predicts Functional Recovery in Liver Grafts During Machine Perfusion: A First-in-Field Ex Vivo Study
Nabeel M (IN)
16:15
Longitudinal body composition changes following pre-donation defatting programs in living liver donors: a CT-based analysis
Francesca Albanesi (IT)
Room C4.6
Engineering immune compatibility in transplantation: Gene editing, cell therapy, and regenerative strategies
Engineering immune compatibility in transplantation: Gene editing, cell therapy, and regenerative strategies
Presentations
Oral Presentation
Construction and properties characterization of a novel ceramic membrane-based artificial kidney hemofilter
Luoyi Chen (CN)
Immortalized Hypoimmune Human Mesenchymal Stem Cells for Immunomodulation and Wound Healing
Katrin Hacke (US)
Periportal arginine deficiency drives macrophage senescence to blunt aged liver regeneration
Haoran Hu (CN)
Preventive Effect of Human-Induced Renal Progenitor Cells on Delayed Graft Function After Kidney Transplantation in Rats
Haiwei Chen (CN)
Room C4.7
Solving immune problems for the life of the allograft
Solving immune problems for the life of the allograft
Chairs
Xunrong Luo (CN) · Kieran Halloran (CA)
Presentations
15:30
Single cell transcriptomic profiling focusing on donor reactive T cells of operational tolerance recipient after liver transplantation
Naoki Tanimine (JP)
15:40
🎗10-year outcomes for autologous polyclonal ex-vivo-expanded Treg cellular therapy in renal transplantation (ONE study UK Treg Trial)
Charlotte Yates (GB)
15:50
Single cell spatial technologies in kidney allograft pathology- inflammation, fibrosis and beyond
Mariam Alexander (US)
16:10
Direct and indirect allorecognition – more alike than we thought?
Gavin Pettigrew (GB)
Room C4.8
Precision virology in transplantation: Immunity, diagnostics, and targeted therapies
Precision virology in transplantation: Immunity, diagnostics, and targeted therapies
Chairs
Matthew Roberts (AU) · Tina Marinelli (AU)
Presentations
Oral Presentation
15:30
The post-transplant lymphoproliferative disorders metagenomic shotgun microbial sequencing (PTLD-MSMS) study: clinical insights from the full cohort
Vikas Dharnidharka (US)
15:40
Phase I Clinical Evaluation of Allogeneic Virus-Specific T Cell Therapy in Solid Organ Transplant Recipients with Refractory Viral Infections
Rajiv Khanna (AU)
15:50
Measles immunity before and after solid organ transplantation: evidence for preserved protective neutralizing antibody
Camille N. Kotton (US)
Mini-Oral Presentation
16:00
Proximal Tubule-Derived SPP1 Activates Proteotoxic Stress Response and CD8⁺ T Cell Exhaustion in BK Polyomavirus Nephropathy
Yingzhen He (CN)
16:07
Virologic clearance with maribavir by baseline cytomegalovirus DNAemia in solid organ transplant recipients: A post hoc analysis of phase 2 and 3 trials
Deepali Kumar (CA)
16:14
Comparing the post-omicron transplant impact of SARS-COV2 and other respiratory viral infections
Beatrice Sim (AU)
Rapid-Fire Presentation
16:21
Real-world effectiveness and safety of maribavir in solid organ transplant recipients with refractory/resistant cytomegalovirus or intolerance to anti-cytomegalovirus drugs: Interim results from the ARISE study
Nassim Kamar (FR)
16:26
Real-world CMV hyperimmunoglobulin prophylaxis in heart and lung transplantation: one-year interim results from a prospective multicenter study
Markus Barten (DE)
16:31
Real world efficacy of maribavir when used as pre-emptive therapy for cytomegalovirus reactivation in alloHCT patients who are intolerant, refractory or resistant
Violet Zhu (AU)
16:36
Donor-Derived Severe Dengue in a Kidney Transplant Recipient Uncovered Pathogenic Neutrophil Inflammation and Protective CD14+ Monocyte Antiviral Programs
Ying Su (CN)
Room C4.9
TTS-ISN: Pregnancy in renal transplant recipients - Outcomes, barriers, and clinical management
TTS-ISN: Pregnancy in renal transplant recipients - Outcomes, barriers, and clinical management
Chairs
Curie Ahn (KR) · Lisa A. Coscia (US)
in collaboration with:
Presentations
15:30
Assessing risk and overcoming barriers in pregnancy after kidney transplantation
Shilpanjali Jesudason (AU)
15:50
Pregnancy after kidney transplantation: Beyond clinical outcomes—understanding barriers and experiences of first nations women
Nishanta Tangirala (AU)
Co-presenting on Pregnancy after kidney transplantation: Beyond clinical outcomes—understanding barriers and experiences of first nations women
Kelli Owen (AU)
16:10
Supporting pregnancy in transplant recipients: current best practice care and controversies
Sumoyee Basu (GB)
Room C4.11
Integrated machine perfusion strategies for DCD organ optimization and transplant outcomes
Integrated machine perfusion strategies for DCD organ optimization and transplant outcomes
Chairs
John Whitlam (AU) · Irene Bello (ES)
Presentations
Oral Presentation
15:30
Sequential NRP and hypothermic versus normothermic ex-situ perfusion in extended criteria DCD liver transplantation
Daniele Pezzati (IT)
Mini-Oral Presentation
15:40
A pragmatic alternative to commercial perfusion devices: routine liver machine perfusion using a heart–lung machine
Mikhail Boldyrev (RU)
15:47
Early outcomes after sequential hypothermic, controlled oxygenated rewarming and normothermic machine perfusion combined with TPA thrombolysis for DCD liver graft optimisation
Adam Philipoff (AU)
Rapid-Fire Presentation
15:54
🎗Automated and continuous hypothermic to normothermic machine perfusion minimises injury in porcine livers and restores function in high-risk human livers
Hatem Sadik (GB)
16:00
Routine use of the modified HTK-based perfusate for hypothermic oxygenated perfusion enables safe transplantation of suboptimal liver allografts: a single center experience
Stepan Zubenko (RU)
16:05
Impact of Hypothermic Oxygenated Machine Perfusion on Early Outcomes in Kidney Transplantation from Uncontrolled Donors
Elmira Tenchurina (RU)
16:10
Factors Associated with Prolonged Case Time in Deceased Organ Donation
Carolyn Sidoti (US)
16:15
Combined liver-kidney normothermic machine perfusion with bioartificial liver support for 48-hour ex vivo recovery of donation after circulatory death organs
Zibiao Zhong (CN)
16:20
Liver and combined liver-pancreas grafts from pediatric DCD donors utilizing normothermic regional perfusion – age or size should not limit the practice
David Walls (US)
Room C4.10
ISOT: Redefining organ transplantation in resource-limited settings: Access, affordability, and global leadership from India - Part 2
ISOT: Redefining organ transplantation in resource-limited settings: Access, affordability, and global leadership from India - Part 2
Workshop Sessions / Industry Symposium / Poster Sessions
Room C4.6
Multidisciplinary: Leveraging shared infrastructure for hematopoietic stem cell and solid organ transplantation
Multidisciplinary: Leveraging shared infrastructure for hematopoietic stem cell and solid organ transplantation
Presentations
16:45
The challenge of siloed program building vs. opportunities of integration
Markus Selzner (CA)
16:57
Immunologic bridge
Rajdeep Das (US)
17:09
One pathogen, two populations
Monica Slavin (AU)
17:21
Beyond the graft
Teun van Gelder (NL)
17:33
Panel discussion on global perspectives on integration and innovation
Discussion Period (AU)
Room C4.7
Approaching and navigating difficult conversations with transplant patients
Approaching and navigating difficult conversations with transplant patients
Chairs
David Thomson (ZA) · Lisa Keller (AU)
Presentations
16:45
Conversations around kidney transplant evaluation: Who and how to communicate non-eligibility for transplant
Rhiannon Reed (US)
17:02
Palliative care post-transplant: Throughout patient journey and symptom management
Kathryn Ducharlet (AU)
17:19
Navigating through organ failure to transplant: Liver transplant
Suk Kyun Hong (KR)
17:36
Navigating conversations on cardiac mechanical support therapy to heart transplant
Shunichi Nakagawa (US)
Hall 1-2
Poster Session 2
Poster Session 2
Room C3.3
Corporate Symposium on State-of-the-Art care for kidney transplant recipients: Implications for the forthcoming KDIGO guideline update
Corporate Symposium on State-of-the-Art care for kidney transplant recipients: Implications for the forthcoming KDIGO guideline update
This program is supported by an independent educational grant from Veloxis Pharmaceuticals, Inc.
Presentations
17:00
Opening Remarks
Germaine Wong (AU)
17:05
KDIGO's plans to update the KTR GL: What has changed and what new topics to consider
Michelle Josephson (US)
17:20
Therapeutic needs assessment in KTRs: Findings from an AST Survey
John S. Gill (CA)
17:35
What's new and exciting in kidney transplantation research: Implications for guidelines, clinicians, and transplant recipients
Germaine Wong (AU)
17:50
Closing Remarks
Germaine Wong (AU)
Networking Events
Cockle Bay 1
TSANZ Networking Event
TSANZ Networking Event
Room C4.4
International Mentee-Mentor Awards Networking Event
International Mentee-Mentor Awards Networking Event
No lectures assigned yet.
ICC Grand Ballroom
Congress Networking Event “Global Connections: Celebrating 60 years”
Congress Networking Event “Global Connections: Celebrating 60 years”
No lectures assigned yet.
Wednesday, September 23, 2026
Parkside 1&2
Biogen Corporate Breakfast Symposium on Microvascular inflammation: A defining characteristic of antibody mediated rejection in kidney transplantation
Biogen Corporate Breakfast Symposium on Microvascular inflammation: A defining characteristic of antibody mediated rejection in kidney transplantation
Chair
Steve Chadban (AU)
Supported by
Presentations
07:00
Greeting and welcome remarks
Steve Chadban (AU)
07:15
Microvascular inflammation and long-term outcomes: current evidence and unmet needs
Steve Chadban (AU)
07:25
Key pathological drivers of antibody-mediated rejection and microvascular inflammation
Katharina Mayer (AT)
07:35
Targeting CD38+ immune cells in antibody-mediated rejection and microvascular inflammation
Katharina Mayer (AT)
07:45
Q&A discussion
Discussion Period (AU)
Morning Abstract and Concurrent Sessions
Cockle Bay 1
Basic mechanisms of experimental kidney allograft injury
Basic mechanisms of experimental kidney allograft injury
Chairs
Shane Grey (AU) · Ana Konvalinka (CA)
Presentations
Oral Presentation
08:00
SPP1 as a predictive biomarker and therapeutic target in fibrotic
Zeping Gui (CN)
Rapid-Fire Presentation
08:10
FCGR4+ Macrophages Promote Endothelial Cell Injury by Antibody-Dependent Cellular Phagocytosis in Antibody-Mediated Rejection after Kidney Transplantation
Bin Ni (CN)
08:16
Histidine metabolism arms macrophages against chronic kidney
Ming Zheng (CN)
08:22
🎗Mitochondrial injury in human and mouse kidneys with ischemia reperfusion injury
Slaghaniya Neupane (CA)
08:28
METTL3 Potentiates M2 Macrophage-Driven MMT to Aggravate Renal Allograft Fibrosis via the TGF-β1/Smad3 Pathway
Dajin Chen (CN)
08:34
TLS-mediated B cell–SPP1⁺ macrophage–EndMT axis drives renal allograft fibrosis and its modulation by Iguratimod
Lei Jiang (CN)
08:40
CX3CL1⁺ HEV licenses gut-imprinted CX3CR1+ myeloid cells to form an ectopic TLS niche and drive chronic renal allograft dysfunction
Lei Jiang (CN)
08:46
Nintedanib significantly attenuated the progression of chronic allograft nephropathy via the inhibition of macrophage
Runmin Ding (CN)
Cockle Bay 2
Tolerance versus rejection 2
Tolerance versus rejection 2
Chairs
Dong Jin Joo (KR) · Alexandra Sharland (AU)
Presentations
Oral Presentation
08:00
Histopathological and spatial transcriptomic features of immune checkpoint inhibitor-related T cell–mediated rejection after liver transplantation
Wen-Rui Wu (CN)
08:10
A novel depleting anti-CD2 monoclonal antibody for induction of mixed chimerism and allograft tolerance in nonhuman primates
Avery Wilson (US)
08:20
Targeting the CXCL10–CXCR3 Axis Attenuates Macrophage Infiltration and Ameliorates Antibody-Mediated Rejection
Tian Wei (CN)
Mini-Oral Presentation
08:30
NAMPT crotonylation dictates cardiomyocyte autophagy to modulate immune rejection in murine heart transplantation
Ruidong Ding (CN)
08:37
TCF-1+ progenitor-like T cells sustain localized effector responses that mediate allograft rejection
Faruk Sacirbegovic (US)
08:44
🎗Epigenetic Erasure of Pro-inflammatory Programs by VISTA Reshapes Macrophage Fate to Mitigate Acute Cardiac Allograft Rejection
Lifei Liang (CN)
08:51
LEA29Y expression executes a heterogenous protective effect on cardiac transplants in a porcine allograft model
Andrea Bähr (DE)
Room C3.3
Kidney allograft rejection; mechanisms and novel therapeutics
Kidney allograft rejection; mechanisms and novel therapeutics
Chairs
William Mulley (AU) · Roslyn B. Mannon (US)
Presentations
Oral Presentation
08:00
Subthreshold Inflammation Matters: A Continuum Model of TCMR Risk
Aravind Cherukuri (US)
08:10
Microvascular Inflammation(MVI) In The Crosshairs: Do Allo- or Autoantibodies Shape Kidney Allograft Pathology?
Vamsee Chirumamilla (US)
08:20
Augmented washed microbiota transplantation for chronic allograft fibrosis in renal transplantation
Hongdi Cao (CN)
Mini-Oral Presentation
08:30
Clinical outcomes of the use of subcutaneous daratumumab for donor-derived cell-free DNA guided treatment of antibody mediated rejection in asian kidney transplant recipients at the Singapore General Hospital
Sobhana Thangaraju (SG)
Rapid-Fire Presentation
08:37
Upregulation of cell death pathways in kidney rejection
Xinyi Ding (AU)
08:42
Kidney allograft outcomes in acute T cell-mediated rejection accompanied by microvascular inflammation: An inverse probability weighted multicentre cohort study
Jiayue Wang (AU)
08:47
Molecular Diagnosis of kidney allograft rejection using the BHOT gene panel-based HistoMx System in Chinese population: a validation study
Longshan Liu (CN)
Room C3.4-C3.5
Insights into old and new therapeutics 2
Insights into old and new therapeutics 2
Chairs
Philip O'Connell (AU) · Zhejia Tian (DE)
Presentations
Oral Presentation
08:00
Preventing post-transplant squamous cell carcinoma: Q-2361 reverses tacrolimus-induced keratinocyte transformation
James Wells (AU)
08:10
🎗Cellular Senescence Drives Age-Related Resistance to Costimulatory Blockade in Transplantation
Sarah Tsou (US)
08:20
A new treatment for infants with congenital nephrotic syndrome: pre-emptive kidney transplantation along with simultaneous bilateral nephrectomy
Lan Zhu (CN)
Mini-Oral Presentation
08:30
Sequential CD38 Monoclonal Antibody Induction Followed by Azathioprine Maintenance versus Continuous CD38 Therapy for Chronic Active Antibody-Mediated Rejection: A NK Cell-Targeted Comparative Study
Yu Cui (CN)
08:37
🎗Senolytic therapy drives immune remodeling in the aged kidney microenvironment
Martin Jaros (DE)
Rapid-Fire Presentation
08:44
🎗Tacrolimus-resistant regulatory T cells in allotransplantation
Naeem Abdul Ghafoor (GB)
08:50
An ROS-responsive targeted nanoplatform for precise rapamycin delivery to alleviate hepatic ischemia–Reperfusion injury
Yuhang Li (CN)
Room C3.6
Key components of an ideal high volume transplant program setup: A global surgical perspective
Key components of an ideal high volume transplant program setup: A global surgical perspective
Chairs
Dieter Broering (SA) · Meng Qingze (CN)
Presentations
08:00
The American perspective
Robert A. Montgomery (US)
08:12
The European perspective
Jiri Fronek (CZ)
08:24
The Asian perspective
Ashwin Rammohan (IN)
08:36
The Oceania perspective
Henry Pleass (AU)
08:48
Panel discussion
Discussion Period (AU)
Room C4.1
Metabolic dysfunction and liver transplantation
Metabolic dysfunction and liver transplantation
Presentations
08:00
Obesity, diabetes and MAFLD- A target or bystander?
Dinesh Jothimani (IN)
08:20
Getting the right patients to transplant: Patient selection, pre-transplant evaluation, and organ allocation in MAFLD
Kymberly Watt (US)
08:40
Optimising outcomes in patients with obesity after transplant: lifestyle modification, bariatric surgery or lifelong GLP1 therapy?
Marina Berenguer (ES)
Room C4.4
LMIC health system strengthening in transplantation: Improving access sustainably in Africa
LMIC health system strengthening in transplantation: Improving access sustainably in Africa
Chair
David Thomson (ZA)
Presentations
08:00
AFRAN: Who we are and what we offer
Intissar Haddiya (MA)
08:08
Rwanda
Emmanuel Muhawenimana (RW)
08:16
Ethiopia
Mekdim Tadesse Siyoum (ET)
08:24
Nigeria
Olalekan Olatise (NG)
Egypt
Refaat Kamel (EG)
08:40
Panel discussion
Discussion Period (AU)
Panelist
Nadey Hakim (GB)
Room C4.5
Immune tolerance, biomarkers, and chronic allograft injury in liver transplantation
Immune tolerance, biomarkers, and chronic allograft injury in liver transplantation
Chairs
Nancy Kwan Man (HK) · Björn Nashan (CN)
Presentations
Oral Presentation
08:00
ANXA1 and FPR signaling promotes immune tolerance by suppressing neutrophil extracellular traps after pediatric liver transplantation
Shuangqing Han (CN)
08:10
Regulatory dendritic cell infusion and early immunosuppressive drug withdrawal in adult live donor liver transplantation
Angus Thomson (US)
08:20
🎗Liver-resident natural killer cells promote immune tolerance after liver transplantation via the PDL1/PD1 axis: Toward engineered cell therapy
Haitao Huang (CN)
Mini-Oral Presentation
08:30
Tumor burden rather than incidence of acute rejection indicates 1-year OFS and RFS
Jiwei Qin (CN)
08:37
Pretransplant natural killer cell activity predicts hpatocellular carcinoma recurrence and survival after living donor liver transplantation
Ho Joong Choi (KR)
08:44
🎗Integrative Transcriptomics and Machine Learning Identify Inflammatory and Profibrotic signalling as a Central Driver of Immune-Mediated Fibrosis in Chronic Liver Allograft Rejection.
Marco Santillán Pazmiño (AR)
Rapid-Fire Presentation
08:51
Impact of the high baseline anti-A/B antibody titer on the clinical outcomes in ABO-incompatible living donor liver transplantation
Jai Young Cho (KR)
08:56
Iguratimod attenuates chronic allograft fibrosis by inhibiting macrophage–myofibroblast transformation via NCOA4-dependent ferritinophagy
Hongdi Cao (CN)
Room C4.6
Ethics and kidney transplantation
Ethics and kidney transplantation
Presentations
Oral Presentation
08:00
🎗Operational guidelines for the National kidney swap transplantation program in India: A modified Delphi Consensus by Indian Society of Organ Transplantation and National Organ and Tissue Transplant Organization
Pranjal Kashiv (IN)
08:10
The role of comorbidities and insurance type in explaining intersectional racial and gender disparities in kidney transplant waitlisting: A mediation analysis
Annika Gompers (US)
08:20
The kidney waiting list index (KiWI): Design and validation of the aotearoa New Zealand kidney transplant waiting list score
Helen L. Pilmore (NZ)
Mini-Oral Presentation
08:30
Residential Neighborhood Social Capital and Access to Live Donor Kidney Transplantation
Mara McAdams DeMarco (US)
08:37
Economic evaluation of the Proposed Kidney Only Allocation Algorithm (KOALA) in Australia
Yitong Yao (AU)
Rapid-Fire Presentation
08:44
Ethnicity and early clinical outcomes in older adult kidney transplant recipients: insights from a multi-ethnic cohort
Zhan Yi Lim (GB)
08:49
Graft outcomes following selective delisting of unacceptable HLA antigens in highly sensitised kidney transplant recipients within a multi-ethnic population
Zhan Yi Lim (GB)
08:54
Ethical and cultural dimensions of deceased organ donation consent in a multinational trauma ICU: A five-year experience from the United Arab Emirates
Ammar Abdelhadi (AE)
Room C4.7
Advancing islet and stem cell transplantation: Immune modulation, bioengineering, and graft survival
Advancing islet and stem cell transplantation: Immune modulation, bioengineering, and graft survival
Presentations
Mini-Oral Presentation
08:00
A multi-centre study of Belatacept and Sirolimus for human islet transplantation
Natasha Rogers (AU)
08:07
The potential of Macaca fuscata, as a recipient model for porcine islet xenotransplantation
Naoaki Sakata (JP)
08:14
Subcutaneous cell sheet transplantation as a superior strategy to intraportal route for induced pluripotent stem cell-derived pancreatic islet cells therapy
Koki Kurahashi (JP)
08:21
Engineering Pancreatic Islet Organoids with a Hierarchical Vascular Network
Jialin Cui (JP)
08:28
Development of a Pre-vascularized Subcutaneous Site Using a Clinically Available Bioabsorbable Device for Islet Transplantation
Norio Emoto (JP)
08:35
Generation of ISL1-Overexpressing Islets with Enhanced Resistance to Apoptosis and Ferroptosis Improves Transplantation Outcomes
Ying Wang (CN)
Rapid-Fire Presentation
08:42
Immune cell and serum cytokine dynamics in islet transplant recipients receiving Belatacept/Sirolimus versus Tacrolimus/Mycophenolate
Rachel Cheong (AU)
08:47
PTBP1 promotes autophagy via the Slc22a17/Lcn2 axis to alleviate apoptosis in grafted islets
Jingwen Wang (CN)
08:52
Pharmacological Inhibition of mtROS-ARA-12-HETE Axis Enhances the Function and Therapeutic Potential of Stem Cell-Derived β Cells for Diabetes
Huanjing Bi (CN)
Room C4.8
CMV and BK virus in transplant recipients: Pearls from the guidelines and emerging frontiers
CMV and BK virus in transplant recipients: Pearls from the guidelines and emerging frontiers
Presentations
08:00
Pearls from the BK guidelines
Nassim Kamar (FR)
08:15
Pearls from the CMV guidelines
Camille N. Kotton (US)
08:30
Beyond the guidelines- new developments and future directions: BK
Germaine Wong (AU)
08:45
Beyond the guidelines - new developments and future directions: CMV
Atul Humar (CA)
09:00
Panel discussion: challenging BK case, challenging CMV case
Discussion Period (AU)
Room C4.9
Pediatric general
Pediatric general
Chairs
Bethany J. Foster (CA) · Henry H L Wu (AU)
Presentations
Oral Presentation
08:00
Dysregulated succinate metabolism in M1 macrophages promotes hepatic stellate cell activation and graft fibrosis after pediatric liver transplantation
Zhixin Zhang (CN)
08:10
Protective anti-HBs thresholds and risk of De Novo hepatitis B after pediatric liver transplantation using anti-HBc–positive donor grafts
Figen Ozcay (TR)
Mini-Oral Presentation
08:20
Pediatric organ donation after circulatory death in the United States
Matthew Goldstein (US)
08:27
Long-term outcomes of pediatric donation after circulatory death (DCD) liver transplantation: Preliminary results from an European liver transplant registry study
Francesca Albanesi (IT)
08:34
Paediatric Lung Transplantation for Pulmonary Hypertension: Excellent Outcomes in a Nationally Centralised Program
Simone Gong (AU)
Rapid-Fire Presentation
08:41
Identifying an appropriate KDPI max value for paediatric renal recipients
Fiona Hudson (AU)
08:46
Measles-Mumps-Rubella vaccination after paediatric heart transplantation
Anne Dipchand (CA)
08:51
International Comparisons of Paediatric Organ Donation Systems: a Mixed-Methods Systematic Review of Policies, Practices, and Interventions Associated with Higher Consent Rates
Leah McLaughlin (GB)
Room C4.10
HLA, antibodies, and alloimmune risk in transplantation: Kidney-focused insights with cross-organ relevance
HLA, antibodies, and alloimmune risk in transplantation: Kidney-focused insights with cross-organ relevance
Chairs
Anne Halpin (CA) · Suzan Warner (AU)
Presentations
Oral Presentation
08:00
Angiotensin II type I receptor antibodies are associated with retransplantation in liver allografts
Jeyamani Ramachandran (AU)
08:10
Early twice-daily dosing of extended-release tacrolimus improves target trough attainment after kidney transplantation: A prospective randomized controlled study
Ziyan Yan (CN)
08:20
2026 Update of the Serologic Nomenclature for Factors of the HLA System; its impact in listing Unacceptable HLA antigens and DSA assessment
Marcelo Fernandez Viña (US)
Rapid-Fire Presentation
08:30
Impact of preformed donor specific antibodies on rejection, allograft survival and mortality in kidney transplant recipients: An Australian registry study
Paayal Naidu (AU)
08:35
Evaluating the Impact of Shared Eplets on Cross-Reactivity in Single Antigen Bead Assays Using Customized HLA Bead Panels
Daiki Iwami (JP)
08:40
Donor specific antibodies in paediatric liver allograft T cell mediated rejection
Suzan Warner (AU)
08:45
Acute Rejection in Pediatric Kidney Transplantation: The Central Role of De Novo Donor-Specific Antibodies and Impact of Targeted Therapy on Graft Outcomes
Alaa Alsaqqa (AE)
08:50
Molecular pathological diagnosis and clinical decision-making system based on mRNA expression profile and immunohischemistry in kidney transplantation
Ping Lan (CN)
Room C4.11
Beyond static cold storage: Hypothermic machine perfusion in transplantation—from mechanisms to clinical impact
Beyond static cold storage: Hypothermic machine perfusion in transplantation—from mechanisms to clinical impact
Chairs
John Whitlam (AU) · Susanna Lam (AU)
Presentations
Oral Presentation
08:00
A next-generation multicomponent perfusion solution targeting mitochondrial reverse electron transport and ferroptosis for hypothermic oxygenated machine perfusion of donor organs
Boris Yaremin (RU)
Mini-Oral Presentation
08:10
Hypothermic oxygenated perfusion improves recipient survival in a rodent model of allogeneic intestinal transplantation
Koki Takase (US)
08:17
🎗First experience with hypothermic oxygenated perfusion of human uteri: Feasibility and metabolic characterization
Keyue Sun (US)
08:24
Real-World Use of Hypothermic Machine Perfusion: Trends and Impact on Short-Term Kidney Allograft Outcomes
Alexander Cortez (US)
08:31
Comparative Efficacy of Continuous Hypothermic Machine Perfusion, Hybrid Machine Perfusion with Static Cold Storage, and Static Cold Storage Alone on Kidney Transplant Outcomes: A Single-Center Cohort Study
Valeria Ripa (US)
08:38
Beyond static cold storage: active hypothermic lung preservation at 10°C using perfusion and CPAP in a porcine model
Irene Bello (ES)
Rapid-Fire Presentation
08:45
Transplanting green kidneys in the era of machine perfusion
Greta Gurry (AU)
08:50
Comparative Analysis of Short-Term Outcomes of Hypothermic Oxygenated Machine Perfusion Versus Static Cold Storage in Deceased Donor Liver Transplantation: A Single-Centre Experience
Kandarpa Akhil (IN)
08:55
🎗Hypothermic oxygenated machine perfusion for partial grafts in a porcine model simulating living donor liver transplantation
Ayaka Satoh (JP)
Room C4.4
LMIC Health System Strengthening in Transplantation: Improving Access Sustainably in Pacific Asia
LMIC Health System Strengthening in Transplantation: Improving Access Sustainably in Pacific Asia
Presentations
09:10
Vitalink: Who we are and what we offer
Curie Ahn (KR)
09:18
Philippines
Rose Marie Rosete-Liquete (PH)
09:26
Indonesia
Henny Puspitasari (ID)
09:34
Vietnam
Thu Du (VN)
09:42
Fiji
Anis Ta'eed (FJ)
09:50
Panel Discussion
Discussion Period (AU)
Abstract and Concurrent Sessions
Cockle Bay 1
ABO-incompatible kidney transplantation and antibody mediated rejection
ABO-incompatible kidney transplantation and antibody mediated rejection
Chairs
Kate Wyburn (AU) · Peter Hughes (AU)
Presentations
Oral Presentation
09:15
ABO-compatible kidney allocation with ABO-adjusted CPRA
Michal Mankowski (US)
09:25
ABO-incompatible kidney transplantation without desensitization - A German multicenter cohort study
Martina Koch (DE)
Mini-Oral Presentation
09:35
Luminex mixed bead and single antigen bead assays have high positive percentage agreement for HLA-A, B and DR, with less agreement identified at HLA-DQ
Petrina Guthrie (AU)
09:42
Clinical outcomes and prognostic factors of ABO-incompatible kidney transplantation: A single-center retrospective study using propensity score matching
Myung Yup Hyun (KR)
09:49
Combination Strategies with Daratumumab to Mitigate Rebound in Kidney Transplant ABMR: A Real-World Study
Xiantian Pan (CN)
09:56
Clinical Practice of Complement C5 Monoclonal Antibody in ABO-Incompatible Living Related Donor Kidney Transplantation
Puxun Tian (CN)
Cockle Bay 2
Ischaemia reperfusion injury
Ischaemia reperfusion injury
Chairs
Stephen Alexander (AU) · Haibo Wang (CN)
Presentations
Oral Presentation
09:15
THBS1 Acts as an Intracellular "Brake" to Orchestrate Immune Remodeling and Mitigate Post-transplantation Liver Injury
Bowen Wu (CN)
09:25
Mitochondrial Priming and Metabolic Unloading Synergistically Restore Energetics in DCD Hearts: A Combined Cardioplegia-Phase Ischemic Preconditioning and Machine Perfusion-Phase Dialysis Strategy
Priyanka Prem (IN)
09:35
RhoA/ROCK2/MYL9 signaling pathway mediates ischemia-reperfusion injury and fibrosis after liver transplantation
Zhixin Zhang (CN)
Mini-Oral Presentation
09:45
IL-27Rα Deficiency Attenuates Renal Ischemia-Reperfusion Injury via Regulating Macrophage Polarization and Inhibiting Endoplasmic Reticulum Stress
Yingqi Zeng (CN)
Rapid-Fire Presentation
09:52
🎗Translation study to document application of treprostinil for minimizing ischemia-reperfusion injury in donation after circulatory death livers using normothermic machine perfusion
Shambhavi Parab (US)
09:57
🎗Recipient toll-like receptor 4 determines the outcome of ischemia-reperfusion injury in steatotic liver transplantation in mice
Kosuke Tanaka (JP)
10:02
🎗Time resolved proteomic signatures of ischemia–reperfusion injury in a porcine donation after circulatory death simulated liver transplant model using ex vivo machine perfusion
Mun Chae Choi (KR)
Room C3.3
Economics, environment and patient experience in kidney transplantation
Economics, environment and patient experience in kidney transplantation
Chairs
Angela Webster (AU) · Sarah Tsou (US)
Presentations
Oral Presentation
09:15
🎗Impact of different eplet matching strategies on the feasibility and equity of eplet based kidney allocation
James Lan (CA)
09:25
The UAE Journey for Organ Transplantation: Evolution and Clinical Outcomes of a National and Pediatric Program (2017–2026)
Abdalazeez Alghraizat (AE)
Mini-Oral Presentation
09:35
Out-of-pocket expenditure and financial implications of renal transplant in children at a not-for-profit tertiary care hospital in a low-middle-income country
Indira Agarwal (IN)
09:42
Patient perspectives on loneliness and social isolation in people receiving kidney replacement therapy including kidney transplant recipients: An interview study.
Amanda Sluiter (AU)
Rapid-Fire Presentation
09:50
Survival After Kidney Transplantation Versus Dialysis in Waitlisted Patients with Diabetic Kidney Disease : A Target Trial Emulation Study
Jiayue Wang (AU)
09:55
Waitlisting dynamics for kidney transplantation in Aotearoa New Zealand: Suspensions, transplantation and deaths
Nicole DeLa Mata (AU)
Room C3.4-C3.5
Immunoregulation in transplantation 2
Immunoregulation in transplantation 2
Chairs
Xunrong Luo (CN) · Michaela Lucas (AU)
Presentations
Oral Presentation
09:15
NR4A1⁺ Immunoregulatory Macrophages Protect Renal Allografts from Chronic Rejection by Anchoring and Taming CD8⁺ Tissue-Resident Memory T Cells via a Dual-Signal Axis
Chao Yang (CN)
09:25
Ex vivo Genetic Silencing of Donor MHC via Normothermic Machine Perfusion Achieves Long-term Renal Allograft Survival
Tong Chen (CN)
09:35
IL4I1-I3P-AhR Axis-Mediated Tryptophan Metabolic Hijacking Orchestrates an mregDC-Treg Spatial Niche to Promote Allograft Tolerance
Zetao Ding (CN)
Mini-Oral Presentation
09:45
CX3CR1+CD4+ cytotoxic T Cells target cholangiocyte self-antigens to drive autoimmunity in biliary atresia
Wanglong Xiao (CN)
09:52
🎗Spatial dynamics of the T cell response to solid organ transplantation in mice
Amy Prosser (AU)
Rapid-Fire Presentation
10:00
Gut microbiota causally regulates allograft rejection through suppression of T helper 17 cell responses
Yanzhuo Liu (CN)
10:05
Interleukin-27Rα deficiency promotes acute kidney injury through enhancing M1 macrophages polarization via the JAK1/STAT1 pathway
Chen Feng (CN)
Room C3.6
Advances in organ preservation, perfusion, and peri-transplant monitoring across liver, kidney, and pancreas transplantation
Advances in organ preservation, perfusion, and peri-transplant monitoring across liver, kidney, and pancreas transplantation
Presentations
Oral Presentation
09:15
Fingerprint in the cold: Perfusate profiling of extended criteria donor livers during hypothermic oxygenated perfusion using Raman spectroscopy
Meryl Copray (NL)
09:25
Sentinel skin flaps for monitoring of pancreas transplants
Helen Stark (GB)
Mini-Oral Presentation
09:38
A four-component reconstruction planning in liver transplantation with 4d flow MRI validation
Bakhtiyar Kazymov (RU)
Rapid-Fire Presentation
09:45
Interim report on NEWHOPE: a first-in-human study on hypothermic machine perfusion with Omnisol preservation solution of deceased donor kidneys prior to transplantation
Liselotte Jeletich (NL)
09:50
Frequency and financial impact of DCD liver procurement dry runs in the normothermic machine perfusion era
Alexander Cortez (US)
09:55
Ischemia-Free Liver Transplantation Reduces the Incidence of New-Onset Diabetes After Transplantation
Ruilin Cai (CN)
10:00
First-in-human multivisceral transplantation using hypothermic oxygenated machine perfusión
Francisco Hernández Oliveros (ES)
10:05
Hypothermic and normothermic combined machine perfusion enables safe transplantation of moderate-to-severe steatotic liver allografts
Mikhail Boldyrev (RU)
10:10
Ischemia-free liver transplantation: 7-year experience from a single-centre cohort in China
Meng Qingze (CN)
Room C4.1
From allorecognition to allocation: Moving toward more individualized kidney transplant matching
From allorecognition to allocation: Moving toward more individualized kidney transplant matching
Chairs
Janette Kwok (HK) · Rhonda Holdsworth (AU)
Presentations
09:15
Importance of HLA beyond the A/B/DR
Anat Tambur (US)
09:35
Beyond HLA: Expanding the immunologic landscape
Toby Coates (AU)
09:55
Precision risk stratification
Wai Lim (AU)
Room C4.2
Advancing equity and innovation in transplantation: From donor assessment to allocation and novel therapies
Advancing equity and innovation in transplantation: From donor assessment to allocation and novel therapies
Chairs
Helen Opdam (AU) · Anette Melk (DE)
Presentations
Oral Presentation
09:15
Timing and allocation trade-offs in liver transplantation for colorectal liver metastases: A decision-analytic study
Quirino Lai (IT)
09:25
Toxoplasma gondii screening and seroprevalence in Australasian deceased organ donors
Madeleine Bangham (AU)
09:35
Simultaneous transjugular intrahepatic portosystemic shunt and intraportal autologous mesenchymal stem cell infusion via a single access route in cirrhotic patients: A first-in-human proof-of-concept study
Sergey Astapovich (RU)
09:45
Transplantation inequities among Hispanic and Latino Americans in the United States: A swim review with quantitative narrative synthesis
Giuseppe Orlando (US)
Mini-Oral Presentation
09:55
Factors contributing to gender disparity in access to kidney replacement therapy in pediatric population in various regions of India: prospective observational multicenter study
Kinnari Vala (IN)
10:02
Preoperative CT volumetry: Diagnostic accuracy and correlation with intraoperative graft weight in living liver donors
Syed Jawad Shah (PK)
10:09
Mechanistic study of PI3K/mTOR signaling pathway combined with immune checkpoint blockade on immune balance in hepatocellular carcinoma and heart transplantation
Xiaolong Miao (CN)
Room C4.5
Post-transplant complications, risk prediction & outcomes
Post-transplant complications, risk prediction & outcomes
Presentations
Oral Presentation
09:15
Donor liver-derived FGF21 protects against tacrolimus-induced post-transplant diabetes mellitus through regulation of the CerS4/C18:0 ceramide lipotoxicity axis
Xinyu Yang (CN)
Mini-Oral Presentation
09:25
Incidence and Outcomes of Malignancy Following Adult Intestinal Transplantation: A National Cohort Study
Naeem Abdul Ghafoor (GB)
09:32
Osteonecrosis After Liver Transplantation: The Role of Pre-transplant Disease Burden Beyond Corticosteroid Exposure
Eun Sung Jeong (KR)
09:40
Impact of Radiation Therapy on Biliary Complications in Liver Transplantation Recipients with Hepatocellular Carcinoma: A Propensity Score-Matched Analysis
Minha Choi (KR)
Rapid-Fire Presentation
09:47
Independent Risk Factors and Predictors of Maintenance Duration for Tracheostomy in Liver Transplant Recipients: A Comprehensive Multivariable Analysis
Minha Choi (KR)
09:52
Risk Stratification Tool for Primary Nonfunction After Pediatric Liver Transplantation: A Novel Model to Guide Urgent Retransplantation
Shuangqing Han (CN)
09:57
Different knots, similar outcomes: Surgical technique does not influence anastomotic stricture risk in duct-to-duct transplants!
Samith Alwis (AU)
Room C4.6
Immunosuppression in liver and kidney transplantation
Immunosuppression in liver and kidney transplantation
Presentations
Oral Presentation
09:15
CD40L-Target Nanoparticles Co-Delivering Sirolimus and CD28 siRNA for the Suppression of Allogeneic Liver Transplantation Rejection
Xiandong Zeng (CN)
09:25
Imlifidase in highly sensitized kidney transplant recipients with a positive crossmatch against a deceased donor - Results of the French ISKIA Registry
Lionel Couzi (FR)
09:35
Encore presentation: The ConfIdeS study: Imlifidase desensitization results in timelier transplant with superior 1-year eGFR among highly sensitized patients compared to control
Robert A. Montgomery (US)
Mini-Oral Presentation
09:45
Induction immunosuppression strategy and long-term graft and patient survival in contemporary adult liver transplantation: A United States allocation-era reassessment
Isabella Faria (US)
09:52
VISTA positive macrophages define an immature tertiary lymphoid niche in renal allograft tolerance
Rui Shi (CN)
10:00
Tacrolimus Exposure Variability and Viral Infection Risk after Kidney Transplantation: A Stratified Analysis Using TTR and CV
Geunbin Park (KR)
Room C4.7
Long-term outcomes and precision surveillance in heart transplantation: Rejection, vasculopathy, and immune monitoring
Long-term outcomes and precision surveillance in heart transplantation: Rejection, vasculopathy, and immune monitoring
Chairs
Kavitha Muthiah (AU) · Lori J. West (CA)
Presentations
Oral Presentation
09:15
Cardiovascular Magnetic Resonance-Guided Rejection Surveillance in Cardiac Transplantation: Five-year Safety Outcomes
Yiling Situ (AU)
09:25
The role of blood plasma cytokines in the diagnosis of rejection long-term after heart transplantation
Maria Simonenko (RU)
09:35
Progression of cardiac allograft vasculopathy in heart recipients with donor-transmitted coronary atherosclerosis
Stepan Sakhovsky (RU)
Mini-Oral Presentation
09:45
Evaluation of the coronary arteries of a heart transplant using optical coherence tomography
Stepan Sakhovsky (RU)
09:52
HLA mismatch burden and De Novo malignancy after heart transplantation: A single-center Korean cohort study
Darae Kim (KR)
Rapid-Fire Presentation
10:00
Genetic testing yield in heart transplant recipients with an undifferentiated cardiomyopathy – a single centre experience in Western Australia
Ellen McGuckin (AU)
10:05
Long Term Survival and Graft Related Outcomes After Percutaneous Coronary Intervention for Cardiac Allograft Vasculopathy in Contemporary Australian Heart Transplant Recipients
Ajay Dharan (AU)
Room C4.9
Clinical outcomes, perioperative management, and organ utilization in transplantation
Clinical outcomes, perioperative management, and organ utilization in transplantation
Chairs
Pranjal Modi (IN) · Henry Pleass (AU)
Presentations
Mini-Oral Presentation
09:15
Optimal timing of double J stent removal after kidney transplantation: a multicenter KQIPS cohort study
Seung Jae Jason Kim (KR)
09:22
Towards Outpatient Kidney Transplant: A Comparative Analysis of the AWAKE trial versus Standard Kidney Transplantation
Vinayak Rohan (US)
Rapid-Fire Presentation
09:30
The effect of intraoperative thermal kidney insulation on current kidney transplantation surgical practices: a feasibility study.
Amy Hort (AU)
09:35
🎗‘Kidney-First’ Retrieval: A value enhancing approach to organ retrieval
Akshay Kriplani (IN)
09:40
Transplant renal artery stenosis: Validation for a new patho-anatomic classification with systematic review of the literature
Animesh Singla (AU)
09:45
Transplant renal artery stenosis: Proposal for a new patho-anatomic classification using intra-vascular ultrasound
Animesh Singla (AU)
09:50
Lessons learned transplanting single pediatric kidneys into adult recipients - single center experience
Alex Zendel (US)
09:55
Towards extended preservation of human livers during long-term normothermic machine perfusion: The role of bile acids
Xuwenxuan Lucia Xie (AU)
10:00
Donor In-Situ Ischemia Time: A Novel Modifiable Risk Factor for Early Graft Dysfunction in Kidney Transplantation
Paul Robertson (AU)
10:05
Comparative Assessment of Early Graft Injury Using Zero-Time Biopsy After Robotic Versus Open Kidney Transplantation
Anant Kumar (IN)
10:10
To preserve or to ligate? Surgical decision-making in multiple renal artery kidney transplantation: A meta-analysis
Firtantyo Adi Syahputra (ID)
Room C4.10
Transplantation beyond traditional publications
Transplantation beyond traditional publications
Chairs
Stefan Tullius (US) · Macey L. Levan (US)
Presentations
09:15
Special features: A reality check on opportunities and challenges
Fadi Issa (GB)
09:27
Social media: Are we reaching our audience and readership worldwide
Jasper Iske (DE)
09:39
Editorial fellowships: A great opportunity to be involved
Melanie Wyld (AU)
09:51
Topic highlights – Article series
Camille N. Kotton (US)
10:03
Panel discussion
Discussion Period (AU)
Room C4.11
Vascularized tissue engineering and organ-on-chip platforms for transplantation and organ replacement
Vascularized tissue engineering and organ-on-chip platforms for transplantation and organ replacement
Chairs
Maria Siemionow (US) · Subramania Iyer (IN)
Presentations
Oral Presentation
09:15
Single-cell spatial mapping of immune microenvironments across the spectrum of skin rejection in vascularized composite allotransplantation
Sarah Short (GB)
09:25
Application and Mechanism of Bionic Leaf Vein Chip in the Construction of Bioartificial Kidney
Zejiaxin Niu (CN)
09:35
Functional Restoration of Apico-basal Polarity and Vascularization in Liver Organoids: A Highly Physiological Unit for Organ Replacement
Mengyu Gao (CN)
09:45
A Human Vascularized Liver Tissueoid-on-Chip Platform for Dissecting T cell- and Antibody-Mediated Allograft Rejection
Vadim Jucaud (US)
09:55
Modeling Antibody-Mediated Endothelial Activation in a Human Vascularized Heart Wall Tissueoid-on-Chip
Vadim Jucaud (US)
Coffee Break / Last chance to visit Exhibit Area
Hall 1-2
Coffee Break
Coffee Break
No lectures assigned yet.
TTS Connect & Converse Theatre
Meet the TSANZ President & TSANZ award winners
Meet the TSANZ President & TSANZ award winners
Presentations
Discussion with TSANZ President
Nicole Isbel (AU)
Q&A with TSANZ President's Prize Award winner - Clinical paper (to be announced on Sept 22)
Discussion Period (AU)
Q&A with TSANZ President's Prize Award winner - Basic Science paper (to be announced on Sept 22)
Discussion Period (AU)
Plenary and Concurrent Sessions / TTS Business Meeting
Darling Harbour
Plenary Session 3
Plenary Session 3
Presentations
10:45
🎗Adverse pregnancy outcomes driven by tacrolimus blockade of IL-15-dependent differentiation of tissue resident natural killer cells
Brittney Knott (US)
10:55
Immune response and safety of the AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine (adjuvanted RSVPreF3) in immunocompromised (IC) adults with lung or kidney transplant compared to non-IC adults up to 12 months post-vaccination
Steve Chadban (AU)
11:05
Towards transplantable organs: Organoids as a future source for kidney transplantation
Ton J. Rabelink (NL)
11:30
ABO beyond Landsteiner: The next chapter in transplant histocompatibility
Lori J. West (CA)
Room C4.9
Expanding horizons in pancreas transplantation: Outcomes, techniques, and program development
Expanding horizons in pancreas transplantation: Outcomes, techniques, and program development
Chairs
Pablo Uva (AR) · Toby Coates (AU)
Presentations
10:45
Current status of pancreas transplantation: Activity and outcomes around the world
Angelika C. Gruessner (US)
11:10
Donation after circulatory death (DCD) in pancreas transplantation: Logistics, use of normothermic regional perfusion (NRP) and outcomes
Joana Ferrer (ES)
11:35
Future of pancreas transplantation in the landscape of emerging therapies
Raja Kandaswamy (US)
Darling Harbour
TTS Business Meeting
TTS Business Meeting
An opportunity for members to receive updates on Society activities, governance, initiatives, and other official business.
No lectures assigned yet.
Lunch Break / Industry Symposia / Lunch with Experts & Mentors
TTS Connect & Converse Theatre
Interview and Q&A discussions with plenary speakers
Interview and Q&A discussions with plenary speakers
Chair
Macey L. Levan (US)
Pyrmont Theatre Foyer
Lunch and Learn Roundtable
Lunch and Learn Roundtable
Presentations
Combined liver–kidney transplantation
Gomathy Narasimhan (IN)
Designing and strengthening organ donation systems
Marti Manyalich Vidal (ES)
Genetic factors influencing transplant outcomes
Stephen Alexander (AU)
Clinical Trials in Kidney Transplantation
Steve Chadban (AU)
From HLA typing to epitope matching
Lucy Sullivan (AU)
Roundtable Mentor
Germaine Wong (AU)
Uterus Transplantation
Mats Brännström (SE)
Encouraging physical activity in transplant recipients with limited endurance or physical limitations
Liz Schick (CH)
Multi-Organ transplantation in children
Tomoaki Kato (US)
SOTA, Thematic and Concurrent Sessions
Cockle Bay 1
Clinical Xenotransplantation has Arrived!
Clinical Xenotransplantation has Arrived!
Presentations
13:45
Understanding optimal genetic modification
Peter Cowan (AU)
14:05
Experience and immunosuppression for clinical xenotransplantation
Muhammad Mohiuddin (US)
14:25
Special challenges of lung xenotransplantation
Richard N. Pierson (US)
14:45
Clinical xenotransplantation: A new era through the eyes of patients and families
Macey L. Levan (US)
Cockle Bay 2
Living Organ Donation in 2026: Unified Principles, Organ-Specific Nuances
Living Organ Donation in 2026: Unified Principles, Organ-Specific Nuances
Chairs
Kwang Woong Lee (KR) · Henry Pleass (AU)
Presentations
13:45
Shared framework for living donor evaluation: medical, psychosocial, and ethical core
Krista Lentine (US)
14:05
Surgical challenges and functional outcomes in living kidney donation
Mireia Musquera (ES)
14:25
Surgical challenges and functional outcomes in living liver donation
Dong Jin Joo (KR)
14:45
Predictive models and global registry insights to enhance donor safety
Allan Massie (US)
Room C3.3
Targeted Therapies and Tailored Dosing: The New Era in ABMR Treatment
Targeted Therapies and Tailored Dosing: The New Era in ABMR Treatment
Chairs
Jen Li (AU) · Lori J. West (CA)
Presentations
13:45
Is there still a role for anti IL-6R in ABMR treatment?
Roslyn B. Mannon (US)
14:05
Is anti-CD38 the most promising agent for ABMR?
Katharina Mayer (AT)
14:25
What does monitoring AUC add compared to C-trough only?
Teun van Gelder (NL)
14:45
Model Informed precision dosing
Anders Asberg (NO)
Room C3.4-C3.5
Pediatric cholestatic liver disease around the world
Pediatric cholestatic liver disease around the world
Presentations
14:05
Alagille syndrome - past, present and future
Susan Mei-Ling Siew (AU)
14:25
Progressive familiar intrahepatic cholestasis differences around the world and the role of medical vs. surgical therapy
Mohamed Rela (IN)
14:45
Primary sclerosing cholangiotis in children and adolescent
Michael Stormon (AU)
Room C3.6
Diversity, Equity, and Inclusion in Gender and Transplantation
Diversity, Equity, and Inclusion in Gender and Transplantation
Chairs
Maria Gomez (AE) · Anette Melk (DE)
Presentations
13:45
Regional and gender disparities in abstracts presented at international transplant congress
Maggie Kam Man Ma (HK)
14:05
Unseen and unequal: Addressing gender and financial disparities in access to kidney transplantation
Nicole Jane Scholes-Robertson (AU)
14:25
Redefining equity: Women, access, and outcomes in liver transplantation
Gomathy Narasimhan (IN)
14:45
Designing gender-responsive transplant policies: Lessons from south and southeast Asia
Chandana Guha (AU)
Room C4.1
Evolving Ethics and Emerging Trends in Transplantation
Evolving Ethics and Emerging Trends in Transplantation
Chairs
David Thomson (ZA) · Aviva Goldberg (CA)
Presentations
13:45
Rating ourselves on the ethics of NRP - How are we doing?
Anji Wall (US)
14:05
Social media use in transplantation
Shaifali Sandal (CA)
14:25
Pediatric prioritization
Thozama Siyotula (ZA)
14:45
Retransplantation after nonadherence (adult & children)
Aaron Wightman (US)
Room C4.5
Innovations in skin cancer in transplantation
Innovations in skin cancer in transplantation
Presentations
13:45
Skin cancer risk prediction and communication
Anne Cust (AU)
14:03
Evaluation of benefits and harms of melanoma screening in chronic disease
Katy Bell (AU)
14:21
Complex surgical oncology
Alexander Varey (AU)
14:39
Novel developments in keratinocyte cancer treatments in Australia
Kiarash Khosrotehrani (AU)
14:57
Panel Discussion
Discussion Period (AU)
Room C4.6
Rise of the Machines: Maximizing donor opportunities in Thoracic Transplantation
Rise of the Machines: Maximizing donor opportunities in Thoracic Transplantation
Chairs
Miranda Paraskeva (AU) · Pablo Sanchez (US)
Presentations
13:45
Debate 1: Pro rapid recovery/no-reanimation for thoracic transplantation
Aaron M. Williams (US)
13:57
Debate 1: Pro ex vivo machine perfusion
Peter MacDonald (AU)
14:09
Debate 2: Pro ex vivo perfusion
Sandra Lindstedt (SE)
14:21
Debate 2: Pro immediate transplant
Gregory I. Snell (AU)
14:33
Expanding the donor pool: Practical implementation of normothermic regional perfusion for DCD heart and lung recovery
Irene Bello (ES)
14:48
Panel Discussion
Discussion Period (AU)
Room C4.7
State of VCA- Present and Future
State of VCA- Present and Future
Chairs
Patrik Lassus (FI) · Hatem Amer (US)
Presentations
13:45
Overview of VCA transplants
Hatem Amer (US)
14:03
VCA becoming part of universal health care
David Leonard (GB)
14:21
Is VCA reconstructive surgery or transplantation
Linda C. Cendales (US)
14:39
Challenges and opportunities for VCA in the global south
Subramania Iyer (IN)
14:57
Standardizing outcomes in VCA: Are we ready for a SONG or for COVER
Allison Jaure (AU)
Room C4.8
Next-Generation Transplantation: Regenerative Medicine Breakthroughs
Next-Generation Transplantation: Regenerative Medicine Breakthroughs
Chairs
Giuseppe Orlando (US) · Vijay Gorantla (US)
Presentations
13:45
The bioartificial kidney: Lessons learned and the road ahead
William Fissell (CA)
14:10
Organoids, organs-on-a-chip, and the path to organ manufacturing
Sean Vincent Murphy (US)
14:35
Engineering vision: Whole-eye transplantation, bioengineering and regeneration
Vijay Gorantla (US)
14:55
Regenerative transplantation: Transforming organ replacement through regenerative medicine
Giuseppe Orlando (US)
Room C4.9
Evolving strategies in intestinal and multivisceral transplantation
Evolving strategies in intestinal and multivisceral transplantation
Chairs
Helen Evans (NZ) · Rajith Amaratunga (AU)
Presentations
13:45
Isolated intestine transplantation for short gut syndrome in the era of GLP-2 agonist
Yaron Avitzur (CA)
14:05
Novel immunosuppression in intestine transplantation
Jennifer Garcia (US)
14:25
Pros and cons of protocol biopsy and stoma
Jonathan Hind (AU)
14:45
Multivisceral transplantation: Patient selection, surgical challenges, and outcomes
Graham Starkey (AU)
Room C4.11
Organ donation following MAID (VAD/euthanasia)
Organ donation following MAID (VAD/euthanasia)
Chairs
Peggy John (CA) · Helen Opdam (AU)
Presentations
13:45
Canadian donation perspective
Matthew Weiss (CA)
14:00
Australian donation perspective
Wade Stedman (AU)
14:15
New Zealand donation perspective
Kim Grayson (NZ)
14:30
Australian MAID/VAD provider perspective
Sara Townend (AU)
14:45
Panel discussion and Q&A
Discussion Period (AU)
Closing Plenary
Parkside 1&2
Closing Plenary
Closing Plenary
Chairs
Nadey Hakim (GB) · John J. Fung (US)
Presentations
15:20
From donor to recipient: Microbiome signatures as predictors of post-transplant complications
Olivia Smibert (AU)
15:45
Gene and cell therapy in transplantation
Maria Grazia Roncarolo (US)
16:10
Closing Remarks
John J. Fung (US)
16:15
Presentation of TTS 2028
Nadey Hakim (GB)
16:22
Invitation to Seoul!
Kwang Woong Lee (KR)